Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal protein binding	KIF21B DLG5 CTTNBP2 MAP1A KIF26A AXL SPATA31A7 TTLL5 OBSCN DBN1 MEFV TAOK2 STARD9 SYNE2 MLPH VPS18 SPATA31A3 BCL2L11 ESPNL TRIOBP MYOZ3 PKD2L1 SHROOM2 LMOD2 SPATA31A5 SHROOM1 SPATA31A1 MARK4 SORBS3 TRAPPC14 AJUBA TNS1	4.30e-05	1099	272	32	GO:0008092
GeneOntologyMolecularFunction	actin binding	MAP1A SPATA31A7 DBN1 MEFV SYNE2 MLPH VPS18 SPATA31A3 ESPNL TRIOBP MYOZ3 SHROOM2 LMOD2 SPATA31A5 SHROOM1 SPATA31A1 AJUBA TNS1	1.09e-04	479	272	18	GO:0003779
GeneOntologyMolecularFunction	complement component C3b receptor activity	CR1 CR1L	1.85e-04	2	272	2	GO:0004877
GeneOntologyMolecularFunction	complement component C4b receptor activity	CR1 CR1L	1.85e-04	2	272	2	GO:0001861
GeneOntologyCellularComponent	cell surface	CFH AXL MCAM IRAK1 TNFRSF10B TNFRSF10A PTPRK KCNC4 AMOT PKD1 SERPINF2 NOTCH3 GOT2 SELE VWF PKD2L1 DUOX2 IL17RC CR1 LCT CR1L MMP25 CD1B CSF3R AOC3 TNFRSF13B ROBO2 TMEM102 FCRL4 TNS1 AGRN	5.42e-05	1111	272	31	GO:0009986
Domain	VWC_out	CRIM1 SSPOP NELL1 FCGBP VWF MUC5B	2.18e-07	19	274	6	SM00215
Domain	VWC	CRIM1 SSPOP NELL1 FCGBP VWF CHRDL2 MUC5B	1.16e-06	38	274	7	SM00214
Domain	VWF_dom	CRIM1 SSPOP NELL1 FCGBP VWF CHRDL2 MUC5B	2.36e-06	42	274	7	IPR001007
Domain	VWFC_1	CRIM1 SSPOP NELL1 VWF CHRDL2 MUC5B	1.27e-05	36	274	6	PS01208
Domain	CCP	CFH SUSD6 CSMD2 SELE CR1 CR1L SNED1	1.33e-05	54	274	7	SM00032
Domain	SUSHI	CFH SUSD6 CSMD2 SELE CR1 CR1L SNED1	1.70e-05	56	274	7	PS50923
Domain	VWFC_2	CRIM1 SSPOP NELL1 VWF CHRDL2 MUC5B	1.76e-05	38	274	6	PS50184
Domain	Sushi_SCR_CCP_dom	CFH SUSD6 CSMD2 SELE CR1 CR1L SNED1	1.91e-05	57	274	7	IPR000436
Domain	DUF4599	SPATA31A7 SPATA31A3 SPATA31C2 SPATA31A5	2.04e-05	12	274	4	PF15371
Domain	DUF4599	SPATA31A7 SPATA31A3 SPATA31C2 SPATA31A5	2.04e-05	12	274	4	IPR027970
Domain	C8	SSPOP FCGBP VWF MUC5B	2.04e-05	12	274	4	PF08742
Domain	TIL	SSPOP FCGBP VWF MUC5B	2.04e-05	12	274	4	PF01826
Domain	C8	SSPOP FCGBP VWF MUC5B	2.92e-05	13	274	4	SM00832
Domain	Unchr_dom_Cys-rich	SSPOP FCGBP VWF MUC5B	2.92e-05	13	274	4	IPR014853
Domain	TIL_dom	SSPOP FCGBP VWF MUC5B	4.04e-05	14	274	4	IPR002919
Domain	VWC	CRIM1 NELL1 VWF CHRDL2 MUC5B	4.88e-05	28	274	5	PF00093
Domain	VWF_type-D	SSPOP FCGBP VWF MUC5B	7.18e-05	16	274	4	IPR001846
Domain	VWFD	SSPOP FCGBP VWF MUC5B	7.18e-05	16	274	4	PS51233
Domain	VWD	SSPOP FCGBP VWF MUC5B	7.18e-05	16	274	4	SM00216
Domain	VWD	SSPOP FCGBP VWF MUC5B	7.18e-05	16	274	4	PF00094
Domain	Sushi	CFH SUSD6 CSMD2 SELE CR1 CR1L	1.09e-04	52	274	6	PF00084
Domain	TMEM88	TMEM88 TMEM88B	2.14e-04	2	274	2	IPR033355
Domain	Ig-like_fold	AXL OBSCN MCAM CAMTA2 PLXND1 NFATC1 PTPRK KAZALD1 HCFC2 PLXNA3 EPM2A SGCA PAPLN TRIM3 SNED1 CD1B CSF3R LRIG1 WFIKKN1 ICAM5 ROBO2 FCRL4 LRIT1	3.14e-04	706	274	23	IPR013783
Domain	-	AXL OBSCN MCAM PLXND1 NFATC1 PTPRK KAZALD1 HCFC2 PLXNA3 EPM2A SGCA PAPLN TRIM3 SNED1 CD1B CSF3R LRIG1 WFIKKN1 ICAM5 ROBO2 FCRL4 LRIT1	3.30e-04	663	274	22	2.60.40.10
Domain	Fol_N	FCGBP SNED1 AGRN	4.72e-04	11	274	3	IPR003645
Domain	FOLN	FCGBP SNED1 AGRN	4.72e-04	11	274	3	SM00274
Domain	Ig_I-set	AXL OBSCN PTPRK KAZALD1 PAPLN LRIG1 WFIKKN1 ICAM5 ROBO2 LRIT1	5.15e-04	190	274	10	IPR013098
Domain	I-set	AXL OBSCN PTPRK KAZALD1 PAPLN LRIG1 WFIKKN1 ICAM5 ROBO2 LRIT1	5.15e-04	190	274	10	PF07679
Domain	TACC	TACC3 TACC2	6.37e-04	3	274	2	PF05010
Domain	ASD1	SHROOM2 SHROOM1	6.37e-04	3	274	2	PF08688
Domain	ASD1	SHROOM2 SHROOM1	6.37e-04	3	274	2	PS51306
Domain	ASD1_dom	SHROOM2 SHROOM1	6.37e-04	3	274	2	IPR014800
Domain	TACC	TACC3 TACC2	6.37e-04	3	274	2	IPR007707
Domain	LDLRA_1	MFRP SSPOP PKD1 MAMDC4 LRP3	6.70e-04	48	274	5	PS01209
Domain	LDLRA_2	MFRP SSPOP PKD1 MAMDC4 LRP3	7.37e-04	49	274	5	PS50068
Domain	CUB	KREMEN2 CSMD2 MFRP CDCP2 LRP3	7.37e-04	49	274	5	PF00431
Domain	CUB	KREMEN2 CSMD2 MFRP CDCP2 LRP3	8.09e-04	50	274	5	SM00042
Domain	EGF_LAM_2	LAMA5 LAMB2 NTN4 AGRN	9.20e-04	30	274	4	PS50027
Domain	EGF_LAM_1	LAMA5 LAMB2 NTN4 AGRN	9.20e-04	30	274	4	PS01248
Domain	-	KREMEN2 CSMD2 MFRP CDCP2 LRP3	9.70e-04	52	274	5	2.60.120.290
Domain	TIG	CAMTA2 PLXND1 NFATC1 PLXNA3	1.04e-03	31	274	4	PF01833
Domain	CUB	KREMEN2 CSMD2 MFRP CDCP2 LRP3	1.06e-03	53	274	5	PS01180
Domain	IPT	CAMTA2 PLXND1 NFATC1 PLXNA3	1.18e-03	32	274	4	IPR002909
Domain	Shroom_fam	SHROOM2 SHROOM1	1.26e-03	4	274	2	IPR027685
Domain	ASD2_dom	SHROOM2 SHROOM1	1.26e-03	4	274	2	IPR014799
Domain	ASD2	SHROOM2 SHROOM1	1.26e-03	4	274	2	PF08687
Domain	PC1	PKD1 PKD2L1	1.26e-03	4	274	2	IPR000434
Domain	TNFR_10	TNFRSF10B TNFRSF10A	1.26e-03	4	274	2	IPR020465
Domain	ASD2	SHROOM2 SHROOM1	1.26e-03	4	274	2	PS51307
Domain	TNFR/NGFR_Cys_rich_reg	TNFRSF10B TNFRSF10A LAMA5 TNFRSF13B	1.33e-03	33	274	4	IPR001368
Domain	EGF_1	HGFAC SSPOP NELL1 NOTCH3 SELE LAMA5 LAMB2 SNED1 NTN4 ADAM33 AGRN	1.42e-03	255	274	11	PS00022
Domain	CUB_dom	KREMEN2 CSMD2 MFRP CDCP2 LRP3	1.47e-03	57	274	5	IPR000859
Domain	LamNT	LAMA5 LAMB2 NTN4	1.52e-03	16	274	3	SM00136
Domain	Laminin_N	LAMA5 LAMB2 NTN4	1.52e-03	16	274	3	IPR008211
Domain	LAMININ_NTER	LAMA5 LAMB2 NTN4	1.52e-03	16	274	3	PS51117
Domain	Laminin_N	LAMA5 LAMB2 NTN4	1.52e-03	16	274	3	PF00055
Domain	EGF_Lam	LAMA5 LAMB2 NTN4 AGRN	1.66e-03	35	274	4	SM00180
Domain	Laminin_EGF	LAMA5 LAMB2 NTN4 AGRN	1.66e-03	35	274	4	PF00053
Pathway	REACTOME_DEATH_RECEPTOR_SIGNALING	OBSCN IRAK1 TNFRSF10B TNFRSF10A ARHGEF17 UBE2D1 USP4 ULK1 FGD3 BCL2L11	1.69e-05	142	184	10	MM15431
Pathway	REACTOME_DEATH_RECEPTOR_SIGNALING	OBSCN IRAK1 TNFRSF10B TNFRSF10A ARHGEF17 UBE2D1 USP4 ULK1 FGD3 BCL2L11	3.40e-05	154	184	10	M27697
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	VWA5B2 KIF26A OBSCN PER1 IRAK1 PLXND1 KDM6B PRAG1 ZDHHC8 TAOK2 TNRC18 NFATC1 TMEM132A PKD1 SEC16A CACNA1H KAZALD1 ULK1 ABTB2 BAHCC1 PLXNA3 SEMA4F DPH2 FAM193B EP400 BCL2L11 INPP5E POLG HECTD4 LAMA5 LAMB2 PAPLN GRID1 TBC1D17 FAM83H MICALL1 SH3PXD2B ZNF592 BTBD7 MARK4 SORBS3 LRP3 CENPV AGRN	3.59e-18	1105	284	44	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIF21B DLG5 SUSD6 KIF26A PLXND1 KDM6B TAOK2 MAST4 TECPR2 AMOT NYAP2 EP400 INPP5E HECTD4 TRIOBP LAMA5 MICALL1 ZFYVE28 ZNF592 ROBO2 EDEM1	3.40e-09	529	284	21	14621295
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A7 SPATA31A3 SPATA31A5 SPATA31A1	6.45e-08	6	284	4	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A7 SPATA31A3 SPATA31A5 SPATA31A1	6.45e-08	6	284	4	25930072
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	CRIM1 AXL OBSCN DBN1 MAP3K12 MLPH KDM6A NOTCH3 PLXNA3 LAMA5 GRID1	1.71e-06	214	284	11	22199357
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	MYT1L ZNF777 HIC1 CEBPA GATA3 ZKSCAN5 HESX1 MEOX2 PHF1 HOXC9 SEBOX TACC3 ABTB2 PLXNA3 E2F2 TACC2 SIM1 TRIM3 TGIF1 LBX2	1.89e-06	709	284	20	22988430
Pubmed	Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.	CFH CR1 CR1L	2.14e-06	4	284	3	27165610
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	BAHCC1 VPS18 NYAP2 EP400 GRAMD1A ATP10D POLR3E BTBD7	2.18e-06	103	284	8	10819331
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	MYT1L SOX3 CEBPA KCMF1 GATA3 HESX1 PHF1 ZBTB37 NFATC1 SEBOX KDM6A ABTB2 NOBOX PLXNA3 ZNF775 E2F2 CREB3L4 TGIF1 ZNF592 BTBD7 AJUBA	3.73e-06	808	284	21	20412781
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	ZSWIM8 TTLL5 NELL1 TACC3 NOTCH3 VPS18 VWF DLGAP4 TRIOBP LAMA5 LAMB2 TACC2 CBS TRIM3 SORBS3 TJAP1 AGRN	4.34e-06	560	284	17	21653829
Pubmed	C3-dependent mechanism of microglial priming relevant to multiple sclerosis.	CFH CR1 CR1L	5.32e-06	5	284	3	22219359
Pubmed	The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.	CFH CR1 CR1L	5.32e-06	5	284	3	20675597
Pubmed	Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation.	CFH CR1 CR1L	5.32e-06	5	284	3	20962256
Pubmed	Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack.	CFH CR1 CR1L	5.32e-06	5	284	3	23390291
Pubmed	Complement modulation in the retinal pigment epithelium rescues photoreceptor degeneration in a mouse model of Stargardt disease.	ABCA4 CR1 CR1L	5.32e-06	5	284	3	28348233
Pubmed	A directed protein interaction network for investigating intracellular signal transduction.	KIF21B DBN1 KDM6B PRAG1 MAP3K12 ZKSCAN5 UBE2D1 PTPRK SYNE2 TONSL USP4 NOTCH3 GOT2 PLXNA3 FAM193B ZNF775 KCNE3 DLGAP4 PYROXD2 MYOZ3 CBS TGIF1 WFIKKN1 ROBO2 TNS1	6.81e-06	1124	284	25	21900206
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DLG5 ARHGEF17 PRAG1 MAST4 AMOT STARD9 SYNE2 SEC16A ABTB2 WDR62 INPP5E RAB11FIP1 NCKAP5L FAM83H MICALL1 SH3PXD2B MARK4 TMEM102 TRAPPC14 MAP3K21 SH3RF3	9.79e-06	861	284	21	36931259
Pubmed	Extracellular matrix of secondary lymphoid organs impacts on B-cell fate and survival.	LAMA5 TNFRSF13B AGRN	1.06e-05	6	284	3	23847204
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NRIP1 DCAF6 SLC38A9 OBSCN SSPOP MAP3K12 INKA2 TNRC18 NFATC1 TECPR2 RIN2 CACNA1H TRMT13 MLPH KDM6A NOTCH3 FAM149A FAM53A POLG HECTD4 TRIOBP FBXL17 IQCN SHROOM2 AR TSPAN10 TJAP1 GREB1 SH3RF3	1.54e-05	1489	284	29	28611215
Pubmed	Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation.	CFH CR1 CR1L	1.84e-05	7	284	3	28057640
Pubmed	The regulation of the complement system: insights from genetically-engineered mice.	CFH CR1 CR1L	1.84e-05	7	284	3	12914820
Pubmed	Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer.	GATA3 MMP28 AR	1.84e-05	7	284	3	23549873
Pubmed	The human and murine protocadherin-beta one-exon gene families show high evolutionary conservation, despite the difference in gene number.	PCDHB15 PCDHB14 PCDHB10 PCDHB9	1.90e-05	20	284	4	11322959
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SYTL2 OBSCN TMEM132A NCKAP5L EPG5 ZFYVE28 ROBO2	2.01e-05	101	284	7	10997877
Pubmed	A census of human transcription factors: function, expression and evolution.	MYT1L SOX3 SP100 HIC1 GATA3 CAMTA2 ZC3H3 HESX1 MEOX2 HOXC9 DMRT3 NFATC1 NOBOX E2F2 CREB3L4 AR BCL6B TGIF1 TADA2B LBX2 OLIG2	2.15e-05	908	284	21	19274049
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MYT1L CFH NRIP1 ZSWIM8 DCAF6 CRIM1 TTLL5 GATM KDM6B NSUN2 ZKSCAN5 NELL1 PTPRK PKD1 KDM6A VWF POLG HECTD4 TRIOBP PDCD7 SHROOM2 CBS ZNF592 RNF38 OLIG2 SLX4	2.28e-05	1285	284	26	35914814
Pubmed	A GO catalogue of human DNA-binding transcription factors.	ZNF777 SEBOX ZNF775 ZNF576 ZNF592	2.33e-05	42	284	5	34673265
Pubmed	Genetic organization of complement receptor-related genes in the mouse.	CFH CR1 CR1L	2.93e-05	8	284	3	2564419
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	MYT1L CFH KIF21B ABCA4 CTTNBP2 CRIM1 IRAK1 NUTM2D DCDC2B DBN1 MFRP NSUN2 INKA2 NUTM2G UBE2D1 USP4 ABTB2 DPH2 TRUB2 ZFYVE28 GPBP1L1 LRIG1 TRAF3IP3 NUTM2F SLX4	3.59e-05	1242	284	25	30973865
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A7 SPATA31A3 SPATA31A5 SPATA31A1	4.07e-05	24	284	4	32212159
Pubmed	Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury.	CFH CR1 CR1L	4.36e-05	9	284	3	18947875
Pubmed	Transcriptome-based systematic identification of extracellular matrix proteins.	KAZALD1 LAMA5 LAMB2 PAPLN NTN4 AGRN	4.74e-05	79	284	6	18757743
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	SOX3 HIC1 GATA3 HESX1 MEOX2 ZBTB37 HOXC9 DMRT3 NFATC1 E2F2 CREB3L4 BCL6B TGIF1 LBX2 OLIG2	4.80e-05	544	284	15	28473536
Pubmed	Novel skin phenotypes revealed by a genome-wide mouse reverse genetic screen.	ABCA4 NSUN2 USP4 LRIG1 TRAF3IP3	5.50e-05	50	284	5	24721909
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	AXL OBSCN MCAM PTPRK LRIG1 ICAM5 OLIG2 LRIT1	5.98e-05	162	284	8	25826454
Pubmed	Circulating AIM prevents hepatocellular carcinoma through complement activation.	CFH CR1 CR1L	6.20e-05	10	284	3	25284781
Pubmed	Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice.	CFH CR1 CR1L	6.20e-05	10	284	3	8422330
Pubmed	Functional identification of transcription control sequences of the mouse Crry gene.	CR1 CR1L	6.64e-05	2	284	2	8335915
Pubmed	The interaction between factor H and Von Willebrand factor.	CFH VWF	6.64e-05	2	284	2	23991205
Pubmed	Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells.	CR1 CR1L	6.64e-05	2	284	2	10779754
Pubmed	JMJD3 and UTX determine fidelity and lineage specification of human neural progenitor cells.	KDM6B KDM6A	6.64e-05	2	284	2	31959746
Pubmed	Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.	CR1 CR1L	6.64e-05	2	284	2	16444293
Pubmed	Hypoxia/reoxygenation up-regulates death receptor expression and enhances apoptosis in human biliary epithelial cells.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	19643115
Pubmed	Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia.	KDM6B KDM6A	6.64e-05	2	284	2	25132549
Pubmed	GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer.	GATA3 KDM6A	6.64e-05	2	284	2	31685800
Pubmed	Calmodulin suppresses synaptotagmin-2 transcription in cortical neurons.	SYTL2 CAMK1G	6.64e-05	2	284	2	20729199
Pubmed	TG-interacting factor (TGIF) downregulates SOX3 gene expression in the NT2/D1 cell line.	SOX3 TGIF1	6.64e-05	2	284	2	22293114
Pubmed	Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	21272366
Pubmed	Epigenetic Modification of Death Receptor Genes for TRAIL and TRAIL Resistance in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	34198757
Pubmed	[Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on CSF3R mutations and measurable residual disease].	CEBPA CSF3R	6.64e-05	2	284	2	36709108
Pubmed	Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	23498957
Pubmed	Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma.	KDM6B KDM6A	6.64e-05	2	284	2	28197626
Pubmed	TRAIL and immunity: more than a license to kill tumor cells.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	15608691
Pubmed	The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm).	CEBPA CSF3R	6.64e-05	2	284	2	35274287
Pubmed	Expression of HOXC9 and E2F2 are up-regulated in CD133(+) cells isolated from human astrocytomas and associate with transformation of human astrocytes.	HOXC9 E2F2	6.64e-05	2	284	2	17588684
Pubmed	8p21.3 deletion suggesting a probable role of TRAIL-R1 and TRAIL-R2 as candidate tumor suppressor genes in the pathogenesis of multiple myeloma.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	23423784
Pubmed	Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	15356269
Pubmed	Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	23460812
Pubmed	The Epigenetic Regulation of OLIG2 by Histone Demethylase KDM6B in Glioma Cells.	KDM6B OLIG2	6.64e-05	2	284	2	35132566
Pubmed	Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX.	KDM6B KDM6A	6.64e-05	2	284	2	27151432
Pubmed	Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	14576771
Pubmed	Assignment of complement components C4 binding protein (C4BP) and factor H (FH) to human chromosome 1q, using cDNA probes.	CFH CR1	6.64e-05	2	284	2	2977721
Pubmed	GATA-3 expression is not associated with complete pathological response in triple negative breast cancer patients treated with neoadjuvant chemotherapy.	GATA3 AR	6.64e-05	2	284	2	27067807
Pubmed	The extended multidomain solution structures of the complement protein Crry and its chimeric conjugate Crry-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.	CR1 CR1L	6.64e-05	2	284	2	12767833
Pubmed	CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	11464292
Pubmed	The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status.	CFH VWF	6.64e-05	2	284	2	24014239
Pubmed	GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance.	AR GREB1	6.64e-05	2	284	2	30644358
Pubmed	Regulation of complement activity via the alternative pathway in placentas of mouse spontaneous abortions.	CR1 CR1L	6.64e-05	2	284	2	20484840
Pubmed	Targeted inhibition of KDM6 histone demethylases eradicates tumor-initiating cells via enhancer reprogramming in colorectal cancer.	KDM6B KDM6A	6.64e-05	2	284	2	32929331
Pubmed	Expression quantitative trait loci for TNFRSF10 influence both HBV infection and hepatocellular carcinoma development.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	26297860
Pubmed	TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	26138346
Pubmed	Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	21785270
Pubmed	Deficiency of nuclear receptor interaction protein leads to cardiomyopathy by disrupting sarcomere structure and mitochondrial respiration.	NRIP1 DCAF6	6.64e-05	2	284	2	31629737
Pubmed	Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice.	CR1 CR1L	6.64e-05	2	284	2	11698469
Pubmed	TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	16544055
Pubmed	Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones.	CR1 CR1L	6.64e-05	2	284	2	34709768
Pubmed	Expression patterns of GATA3 and the androgen receptor are strongly correlated in patients with triple-negative breast cancer.	GATA3 AR	6.64e-05	2	284	2	27184484
Pubmed	Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.	CR1 CR1L	6.64e-05	2	284	2	7691944
Pubmed	Expression of tumor necrosis factor-related apoptosis-inducing ligand death receptors DR4 and DR5 in human nonmelanoma skin cancer.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	24212133
Pubmed	NRIP, a novel calmodulin binding protein, activates calcineurin to dephosphorylate human papillomavirus E2 protein.	NRIP1 DCAF6	6.64e-05	2	284	2	21543494
Pubmed	hShroom1 links a membrane bound protein to the actin cytoskeleton.	MCAM SHROOM1	6.64e-05	2	284	2	19137261
Pubmed	Histone H3K27 Demethylase Negatively Controls the Memory Formation of Antigen-Stimulated CD8+ T Cells.	KDM6B KDM6A	6.64e-05	2	284	2	30626691
Pubmed	Kdm6b regulates context-dependent hematopoietic stem cell self-renewal and leukemogenesis.	KDM6B KDM6A	6.64e-05	2	284	2	30936419
Pubmed	AKT signaling promotes DNA damage accumulation and proliferation in polycystic kidney disease.	PKD1 INPP5E	6.64e-05	2	284	2	31625572
Pubmed	Clinical and genetic study of Tunisian families with genetic generalized epilepsy: contribution of CACNA1H and MAST4 genes.	MAST4 CACNA1H	6.64e-05	2	284	2	29948376
Pubmed	A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo.	MEOX2 PKD1	6.64e-05	2	284	2	15579506
Pubmed	Role of H3K27 demethylases Jmjd3 and UTX in transcriptional regulation.	KDM6B KDM6A	6.64e-05	2	284	2	21209387
Pubmed	The Maternal Effect Genes UTX and JMJD3 Play Contrasting Roles in Mus musculus Preimplantation Embryo Development.	KDM6B KDM6A	6.64e-05	2	284	2	27384759
Pubmed	Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.	NRIP1 AR	6.64e-05	2	284	2	9368054
Pubmed	Drebrin Isoforms Critically Regulate NMDAR- and mGluR-Dependent LTD Induction.	DBN1 ICAM5	6.64e-05	2	284	2	30349460
Pubmed	Secretory stressors induce intracellular death receptor accumulation to control apoptosis.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	28981087
Pubmed	Human complement factor H is a reductase for large soluble von Willebrand factor multimers--brief report.	CFH VWF	6.64e-05	2	284	2	24008159
Pubmed	Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases.	KDM6B KDM6A	6.64e-05	2	284	2	18003914
Pubmed	Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.	CEBPA CSF3R	6.64e-05	2	284	2	31784538
Pubmed	The murine complement receptor gene family. III. The genomic and transcriptional complexity of the Crry and Crry-ps genes.	CR1 CR1L	6.64e-05	2	284	2	2307848
Pubmed	CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.	CEBPA CSF3R	6.64e-05	2	284	2	27143256
Pubmed	Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	11862476
Pubmed	Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin.	MCAM AMOT	6.64e-05	2	284	2	23389031
Pubmed	TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells.	TNFRSF10B TNFRSF10A	6.64e-05	2	284	2	20430723
Pubmed	Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1.	CR1 CR1L	6.64e-05	2	284	2	1730912
Interaction	TOP3B interactions	VWA5B2 KIF26A KCMF1 OBSCN PER1 IRAK1 PLXND1 KDM6B PRAG1 ZDHHC8 TAOK2 TNRC18 NFATC1 RECQL5 TMEM132A PKD1 SEC16A CACNA1H KAZALD1 ULK1 ABTB2 BAHCC1 PLXNA3 SEMA4F DPH2 FAM193B CAD EP400 BCL2L11 INPP5E POLG HECTD4 LAMA5 LAMB2 PAPLN GRID1 TBC1D17 FAM83H MICALL1 SH3PXD2B ZNF592 BTBD7 MARK4 SORBS3 LRP3 CENPV AGRN	2.93e-08	1470	273	47	int:TOP3B
Cytoband	Ensembl 112 genes in cytogenetic band chr17p13	TMEM88 HIC1 SPEM3 PER1 CAMTA2 KDM6B SERPINF2 BCL6B PIK3R6 TMEM102	6.74e-05	346	284	10	chr17p13
Cytoband	5q31	SLC4A9 PCDHGC4 PCDHB15 PCDHB14 PCDHB10 PCDHB9	8.51e-05	115	284	6	5q31
Cytoband	17p13.1	TMEM88 PER1 KDM6B BCL6B PIK3R6 TMEM102	9.81e-05	118	284	6	17p13.1
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	DELE1 SLC4A9 SLC25A48 PCDHGC4 PCDHB15 PCDHB14 PCDHB10 PCDHB9 SHROOM1	1.12e-04	298	284	9	chr5q31
Cytoband	16p13.3	KREMEN2 MEFV PKD1 CACNA1H TBL3 MMP25 WFIKKN1 SLX4	1.53e-04	244	284	8	16p13.3
Cytoband	4p16.3	TACC3 FAM53A DOK7 LETM1 ZFYVE28	1.92e-04	85	284	5	4p16.3
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	HGFAC TACC3 FAM53A DOK7 LETM1 ZFYVE28 TADA2B	4.99e-04	222	284	7	chr4p16
Cytoband	8q24.3	ZC3H3 RECQL4 TONSL FAM83H ZNF517	7.12e-04	113	284	5	8q24.3
Cytoband	Ensembl 112 genes in cytogenetic band chr9q12	SPATA31A7 SPATA31A5	1.04e-03	8	284	2	chr9q12
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFH SUSD6 CSMD2 SELE CR1 CR1L SNED1	1.44e-06	57	179	7	1179
GeneFamily	Clustered protocadherins	PCDHGC4 PCDHB15 PCDHB14 PCDHB10 PCDHB9	4.28e-04	64	179	5	20
GeneFamily	RecQ like helicases	RECQL5 RECQL4	9.56e-04	5	179	2	1049
GeneFamily	Fibronectin type III domain containing	AXL OBSCN PTPRK SNED1 CSF3R ROBO2 LRIT1	1.09e-03	160	179	7	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	OBSCN KAZALD1 PAPLN LRIG1 WFIKKN1 ROBO2 LRIT1	1.13e-03	161	179	7	593
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	MAP3K12 TAOK2 MAP3K21	1.66e-03	24	179	3	654
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	HIC1 ZBTB37 ABTB2 BCL6B BTBD7 SLX4	2.19e-03	134	179	6	861
GeneFamily	CD molecules\|Tumor necrosis factor receptor superfamily\|Death inducing signaling complex	TNFRSF10B TNFRSF10A TNFRSF13B	2.89e-03	29	179	3	782
GeneFamily	Plexins	PLXND1 PLXNA3	3.35e-03	9	179	2	683
Coexpression	GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP	ZNF777 RGS9 ZKSCAN5 SYNE2 NOTCH3 BAHCC1 NOBOX PLXNA3 DLGAP4 RAB11FIP1 GPBP1L1 ADAM33 GREB1	2.52e-07	199	280	13	M3060
Coexpression	NABA_MATRISOME	VWA5B2 HGFAC CRIM1 PLXND1 ASTL MFRP SSPOP NELL1 KAZALD1 HCFC2 SERPINF2 PLXNA3 SEMA4F COL9A3 VWF CHRDL2 MMP28 LAMA5 LAMB2 CDCP2 PAPLN LGALS12 MUC5B MMP25 SNED1 NTN4 WFIKKN1 ADAM33 CLCF1 AGRN	4.64e-07	1008	280	30	MM17056
Coexpression	NABA_ECM_GLYCOPROTEINS	VWA5B2 CRIM1 SSPOP NELL1 VWF LAMA5 LAMB2 CDCP2 PAPLN SNED1 NTN4 AGRN	1.11e-06	191	280	12	MM17059
Coexpression	NABA_ECM_GLYCOPROTEINS	VWA5B2 CRIM1 SSPOP NELL1 VWF LAMA5 LAMB2 CDCP2 PAPLN SNED1 NTN4 AGRN	1.45e-06	196	280	12	M3008
Coexpression	NABA_MATRISOME	VWA5B2 HGFAC CRIM1 PLXND1 ASTL SSPOP NELL1 KAZALD1 HCFC2 SERPINF2 PLXNA3 SEMA4F COL9A3 VWF CHRDL2 MMP28 LAMA5 LAMB2 CDCP2 PAPLN LGALS12 MUC5B MMP25 SNED1 NTN4 WFIKKN1 ADAM33 CLCF1 AGRN	2.04e-06	1026	280	29	M5889
Coexpression	PEREZ_TP53_TARGETS	DLG5 ZNF777 HIC1 CEBPA SUSD6 KIF26A OBSCN GATA3 GATM ARHGEF17 KCNC4 TECPR2 ULK1 KDM6A SLC30A10 ABTB2 FGD3 FAM149A COL9A3 BCL2L11 MMP28 INPP5E HECTD4 DUOX2 SHROOM2 TRIM3 ZFYVE28 MARK4 GREB1 EDEM1 TNS1	5.69e-06	1201	280	31	M4391
Coexpression	NABA_CORE_MATRISOME	VWA5B2 CRIM1 SSPOP NELL1 COL9A3 VWF LAMA5 LAMB2 CDCP2 PAPLN SNED1 NTN4 AGRN	7.56e-06	270	280	13	MM17057
Coexpression	NABA_CORE_MATRISOME	VWA5B2 CRIM1 SSPOP NELL1 COL9A3 VWF LAMA5 LAMB2 CDCP2 PAPLN SNED1 NTN4 AGRN	9.20e-06	275	280	13	M5884
Coexpression	GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP	KCMF1 SYTL2 GATA3 KMT2E AMOT TMC8 SLC30A10 HECTD4 AR ATP10D TBC1D17	1.11e-05	200	280	11	M5711
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL	CFH ZSWIM8 CRIM1 SUSD6 GATM ZC3H3 FCGBP NFATC1 RIN2 KAZALD1 MLPH SH2D3A MUC5B IL17RC TACC2 CBS FAM83H MICALL1 SH3PXD2B LRIG1 WFIKKN1 EDEM1 CLCF1	1.13e-05	775	280	23	M45713
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	SOX3 HIC1 TCERG1L KREMEN2 MCAM TNFRSF10B ARHGEF17 NELL1 NFATC1 PTPRK PRRG4 SLC30A10 ABTB2 BCL2L11 MMP28 E2F2 RAB11FIP1 CBS MMP25 SNED1 ESYT3 NTN4 SHROOM1 ICAM5 MAP3K21 AJUBA OLIG2 CLCF1	1.38e-05	1074	280	28	M1941
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	NAB2 RNF19B PER1 CAMTA2 KDM6B ZKSCAN5 PHF1 RBM25 UBE2D1 PKD1 PRRG4 ULK1 KDM6A ABTB2 PLXNA3 INPP5E DLGAP4 RAB11FIP1 TBC1D17 GPBP1L1 RNF38 TJAP1 CLCF1	2.85e-05	822	280	23	M6782
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	DBN1 ARHGEF17 AMOT SEC16A ULK1 NOTCH3 CAD EP400 POLG LAMA5 LAMB2 AGRN	4.60e-05	276	280	12	M3063
Coexpression	GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP	HIC1 SUSD6 PER1 KMT2E PHF1 TNRC18 UBE2D1 NFATC1 WFIKKN1 SLX4	6.24e-05	200	280	10	M9748
Coexpression	GSE31082_DN_VS_DP_THYMOCYTE_DN	MCAM KDM6B KMT2E TAOK2 PHF1 PKD1 TRIOBP ZNF592 RNF38 PSD4	6.24e-05	200	280	10	M5055
Coexpression	GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP	KIF21B NAB2 MCAM PER1 MEFV BCL2L11 POLG GRAMD1A TGIF1	6.48e-05	162	280	9	M8243
Coexpression	NABA_BASEMENT_MEMBRANES	LAMA5 LAMB2 PAPLN NTN4 AGRN	6.50e-05	40	280	5	M5887
Coexpression	NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER	HCFC2 VWF PAPLN SNED1 AGRN	7.34e-05	41	280	5	M47988
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	ZSWIM8 GATA3 SEC16A ULK1 MLPH PLXNA3 HECTD4 CREB3L4 KLHDC9 AR TRIM3 SNED1 TADA2B LRP3	7.61e-05	385	280	14	M2840
Coexpression	BENPORATH_EED_TARGETS	SOX3 TMEM88 HIC1 GATA3 PLXND1 MEOX2 NELL1 HOXC9 DMRT3 KCNC4 AMOT KAZALD1 ABTB2 CHRDL2 DUOX2 GRID1 SIM1 TBL3 ZFYVE28 ESYT3 NTN4 SHROOM1 ZNF517 ICAM5 SLC6A5 OLIG2	7.67e-05	1059	280	26	M7617
Coexpression	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	KIF21B SP100 ARHGAP30 TNFRSF10B DBN1 KDM6B PKD1 TRMT13 KDM6A FGD3 KCNE3 POLG TRIOBP RAB11FIP1 CR1 CBS TGIF1 TRAF3IP3 EDEM1 AJUBA SH3RF3	1.06e-04	778	280	21	M17915
Coexpression	GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS	CFH AXL OBSCN MCAM PLXND1 ARHGEF17 NOTCH3 VWF LAMA5 LAMB2 BCL6B SNED1 CSF3R AOC3 ADAM33 TNS1	1.19e-04	505	280	16	M39167
Coexpression	ZHENG_BOUND_BY_FOXP3	NRIP1 SP100 AXL GATA3 PRAG1 PTPRK AMOT SYNE2 ZC3H12D PRRG4 ABTB2 VWF CR1 CR1L LRIG1 TRAF3IP3	1.25e-04	507	280	16	MM1030
Coexpression	LU_AGING_BRAIN_UP	CFH GATM AMOT RIN2 EPM2A VWF CBS TGIF1 LRIG1 GREB1 OLIG2	1.34e-04	263	280	11	M5547
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HIC1 CRIM1 OBSCN MCAM ARHGEF17 KCNC4 STARD9 CACNA1H NOTCH3 GRID1 SHROOM2 AOC3	3.24e-09	188	283	12	ccddc08121caff958a2b6f9e278a018858af6b4d
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CRIM1 SYTL2 MCAM GATM ARHGEF17 KCNC4 CACNA1H NOTCH3 SGCA NTN4 AOC3 ADAM33	3.65e-09	190	283	12	d6b3a92119b210974a32af3fe9875d60eb02761e
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	MCAM ARHGEF17 INKA2 SYNE2 CACNA1H NOTCH3 LAMA5 GRID1 OAZ2 SHROOM2 NTN4	3.82e-08	189	283	11	9c407b17d7945e81e1ae6c18452f5d20fb09d563
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AXL MCAM ARHGEF17 CACNA1H NOTCH3 LAMA5 GRID1 OAZ2 AOC3 TNS1 SH3RF3	6.15e-08	198	283	11	7dd874b09c81cc512ccc1e9b65f290a5f94d736e
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CRIM1 SYTL2 OBSCN MCAM ARHGEF17 STARD9 SYNE2 CACNA1H NOTCH3 AOC3 TNS1	6.82e-08	200	283	11	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CRIM1 SYTL2 OBSCN MCAM ARHGEF17 STARD9 SYNE2 CACNA1H NOTCH3 AOC3 TNS1	6.82e-08	200	283	11	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CRIM1 SYTL2 OBSCN MCAM ARHGEF17 STARD9 SYNE2 CACNA1H NOTCH3 AOC3 TNS1	6.82e-08	200	283	11	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYTL2 GATA3 TNFRSF10B ZC3H12D SEMA4F MAMDC4 ESYT3 ADAM33 TRAF3IP3 PSD4	1.62e-07	172	283	10	33c201aaa98acbf1901b6fa6ce0d3ff8012a4d94
ToppCell	facs-Heart-RV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCAM PHF1 PTPRK CACNA1H NOTCH3 SELE EPM2A GRID1 AOC3 AJUBA	2.11e-07	177	283	10	7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8
ToppCell	facs-Heart-RV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCAM PHF1 PTPRK CACNA1H NOTCH3 SELE EPM2A GRID1 AOC3 AJUBA	2.11e-07	177	283	10	e7b1f3092e6b8d0d580f82648035f5ad12be6961
ToppCell	droplet-Limb_Muscle-Pre-Sort\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRIM1 GATM KDM6B CACNA1H NOTCH3 SELE VWF LAMA5 LAMB2 GREB1	2.47e-07	180	283	10	af2bafcd1b2082629de3ea336711add01565c4c4
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRIM1 GATM KDM6B CACNA1H NOTCH3 SELE VWF LAMA5 LAMB2 GREB1	2.47e-07	180	283	10	f29a995cf6e1a1836ed68b73258d9370bf3d4434
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CRIM1 SYTL2 MCAM ARHGEF17 STARD9 CACNA1H NOTCH3 GRID1 SHROOM2 TNS1	2.60e-07	181	283	10	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF17 SYNE2 CACNA1H NOTCH3 LAMA5 LAMB2 NCKAP5L LRIG1 AOC3 TNS1	3.18e-07	185	283	10	38486b69c48dc5e1c4e1488208fa8954a973eccb
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF17 SYNE2 CACNA1H NOTCH3 LAMA5 LAMB2 NCKAP5L LRIG1 AOC3 TNS1	3.18e-07	185	283	10	3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A KIF26A MCAM KAZALD1 NOTCH3 KCNE3 VWF LAMB2 PKD2L1 AOC3	3.51e-07	187	283	10	ddfc2d1d9fcc3d8e4d3d015576bb17eebf44ada9
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CRIM1 SYTL2 MCAM ARHGEF17 KCNC4 STARD9 CACNA1H NOTCH3 GRID1 AOC3	3.51e-07	187	283	10	fa01a61bfd13feb033ba1e35cf513707b1bff8c8
ToppCell	Adult-Mesenchymal-pericyte_cell\|Adult / Lineage, Cell type, age group and donor	CRIM1 AXL OBSCN MCAM ARHGEF17 STARD9 CACNA1H NOTCH3 TNS1 SH3RF3	3.51e-07	187	283	10	62759efb660179402fb574ce5701c89a2e17bcfe
ToppCell	15-Distal-Mesenchymal-Pericyte\|Distal / Age, Tissue, Lineage and Cell class	CRIM1 MCAM GATM KCNC4 STARD9 NOTCH3 SGCA CBS NTN4 AOC3	3.69e-07	188	283	10	4963382e54aac06bf5047c7d725393db70667ee7
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	CRIM1 SYTL2 MCAM ARHGEF17 KCNC4 CACNA1H NOTCH3 AOC3 ADAM33 LGR6	4.26e-07	191	283	10	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	15-Airway-Mesenchymal-Pericyte\|Airway / Age, Tissue, Lineage and Cell class	CRIM1 MCAM GATM KCNC4 NOTCH3 SGCA OAZ2 NTN4 AOC3 LGR6	4.92e-07	194	283	10	5c1218d239c88082496924653ed2a092dc44a906
ToppCell	Endothelial\|World / shred by cell class for bronchial biopsy	TMEM88 CRIM1 KIF26A MCAM PLXND1 MEOX2 NELL1 SELE VWF BCL6B	5.16e-07	195	283	10	f0e46e859f7a9bdead3203889f7e20fa21f76ff0
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CRIM1 AXL MCAM ARHGEF17 CACNA1H NOTCH3 GRID1 AOC3 LGR6 SH3RF3	5.41e-07	196	283	10	754a3613340932563cd8424d775e18b93c3a1aaa
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	CRIM1 MCAM SYNE2 CACNA1H NOTCH3 SGCA LAMA5 NTN4 AOC3 LGR6	5.41e-07	196	283	10	1d94cecd378a829dd8014fc086d7fca48c953a91
ToppCell	367C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	CRIM1 MCAM SYNE2 CACNA1H NOTCH3 SGCA LAMA5 NTN4 AOC3 LGR6	5.41e-07	196	283	10	aacec48285bcb7ccf1b538187071885e3602cc49
ToppCell	mLN-T_cell-Th1\|mLN / Region, Cell class and subclass	TMEM88 HIC1 MAP1A GATA3 MCAM PER1 RGS9 KDM6B NOTCH3 SHROOM1	5.93e-07	198	283	10	7627b7c3a248da2bd5e1e6f7c226e5fd0bc92113
ToppCell	mLN-(1)_T_cell-(12)_Th1\|mLN / shred on region, Cell_type, and subtype	TMEM88 HIC1 MAP1A GATA3 MCAM PER1 RGS9 KDM6B NOTCH3 SHROOM1	5.93e-07	198	283	10	1fe8257233232b264b9ca630c2d92c509a195353
ToppCell	Bronchial-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CTTNBP2 CRIM1 OBSCN MCAM ARHGEF17 STARD9 CACNA1H NOTCH3 GRID1 SHROOM2	6.21e-07	199	283	10	854628ce91068093c14bd4d45ba38c41469f3549
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CRIM1 AXL MCAM GATM CACNA1H NOTCH3 SGCA NTN4 AOC3 TNS1	6.21e-07	199	283	10	9a08c25bb4851ad4ac9db8916422280f71378c2c
ToppCell	Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CTTNBP2 CRIM1 OBSCN MCAM ARHGEF17 STARD9 CACNA1H NOTCH3 GRID1 SHROOM2	6.21e-07	199	283	10	929f809579368201331d9099d8904b6e3c41797b
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CRIM1 AXL MCAM GATM CACNA1H NOTCH3 SGCA NTN4 AOC3 TNS1	6.21e-07	199	283	10	2ed10c5e15c9d5ed0a8bea580842348d5698a07b
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D231\|Adult / Lineage, Cell type, age group and donor	CRIM1 SYTL2 MCAM ARHGEF17 NOTCH3 SGCA SORBS3 ADAM33 LGR6	8.04e-07	158	283	9	8d64c0c9de910a3f4658778642d183c8b9b6f6a2
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DLG5 HIC1 PRAG1 HOXC9 RIN2 PAPLN SHROOM2 TRAPPC14 CLCF1	1.10e-06	164	283	9	d167c7a987b9b35d1e7725c803df4f9cd5380e47
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	OBSCN ZBTB37 TECPR2 TONSL MMP28 INPP5E CR1L ZNF517 TMEM102	1.34e-06	168	283	9	8697b40b2ec2cce68ef3beb4792eb3eff29be053
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	SYTL2 DBN1 CACNA1H DOK7 LAMA5 LAMB2 MUC5B AJUBA AGRN	1.63e-06	172	283	9	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRIM1 AXL MCAM ARHGEF17 SSPOP INKA2 NOTCH3 PCDHGC4 AJUBA	1.97e-06	176	283	9	f931192e3cc65414e2245354f443473696cc7ce8
ToppCell	droplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRIM1 AXL MCAM ARHGEF17 SSPOP INKA2 NOTCH3 PCDHGC4 AJUBA	1.97e-06	176	283	9	e2b59a904c5c8f9c88e1e63788e9b6485f22edd0
ToppCell	BAL-Control-cDC_8\|Control / Compartment, Disease Groups and Clusters	ZNF777 TTLL5 TNFRSF10B ZDHHC8 HESX1 RECQL5 EPM2A CR1 ZNF592	2.48e-06	181	283	9	f370161afef2ec827a7b194c06abb9ac1a507cbb
ToppCell	normal_Lung-Fibroblasts-Pericytes\|normal_Lung / Location, Cell class and cell subclass	CRIM1 OBSCN MCAM ARHGEF17 INKA2 CACNA1H NOTCH3 SGCA AOC3	2.48e-06	181	283	9	f74941e49950027360d71ea3b205fc20c6929766
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRIM1 KIF26A AMOT VWF LAMB2 CBS BCL6B SHROOM1 LRIG1	2.48e-06	181	283	9	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	Healthy_donor-MAIT\|Healthy_donor / disease group, cell group and cell class (v2)	CFH SYTL2 GATA3 MCAM PER1 DBN1 SYNE2 NTN4 AJUBA	2.60e-06	182	283	9	ac7c83464487ecde3df6804a99551307bd768f21
ToppCell	Adult-Mesenchymal-pericyte_cell-D122\|Adult / Lineage, Cell type, age group and donor	CRIM1 AXL OBSCN MCAM ARHGEF17 CACNA1H NOTCH3 TNS1 SH3RF3	2.72e-06	183	283	9	fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCell	droplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTLL5 TNFRSF10B AMOT TMEM132A KAZALD1 RAB3IL1 WDR62 CREB3L4 BCL6B	2.97e-06	185	283	9	6a85399cfdb9b89683c874e7f046957f9a601dc2
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26A MCAM PLXND1 KAZALD1 KCNE3 VWF LAMB2 PKD2L1 REXO2	2.97e-06	185	283	9	f98af3146ec2f44c30d31a662fb9c4fa3ca4f706
ToppCell	droplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTLL5 TNFRSF10B AMOT TMEM132A KAZALD1 RAB3IL1 WDR62 CREB3L4 BCL6B	2.97e-06	185	283	9	64791056cdbb739136dbef08f4b16e2b5427faad
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma\|TCGA-Prostate / Sample_Type by Project: Shred V9	DBNDD1 TMEM132A SEC16A MLPH GRAMD1A CREB3L4 LETM1 TRUB2 LRIG1	2.97e-06	185	283	9	9d53e0a92e4f99370be2e4be1dd737630796b1ca
ToppCell	facs-Heart-LA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCAM ARHGEF17 INKA2 PTPRK SEBOX NOTCH3 SELE AOC3 AJUBA	3.24e-06	187	283	9	a12f383b02b07af32cc53a154685df8dba8fbd3f
ToppCell	facs-Heart-LA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MCAM ARHGEF17 INKA2 PTPRK SEBOX NOTCH3 SELE AOC3 AJUBA	3.24e-06	187	283	9	c40c152fa14e6afc9188549534b64ccbaded56b3
ToppCell	TCGA-Prostate-Primary_Tumor\|TCGA-Prostate / Sample_Type by Project: Shred V9	DBNDD1 TMEM132A SEC16A MLPH GRAMD1A CREB3L4 LETM1 TRUB2 LRIG1	3.24e-06	187	283	9	3e6a95c912dad5d61e10497ffaafd2b9027cd13a
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma\|TCGA-Prostate / Sample_Type by Project: Shred V9	DBNDD1 TMEM132A SEC16A MLPH GRAMD1A CREB3L4 LETM1 TRUB2 LRIG1	3.24e-06	187	283	9	fa0452f3382c22c0391b241d06504fda3c6a19f0
ToppCell	droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A KIF26A MCAM KAZALD1 KCNE3 VWF PCDHB10 MYOZ3 BTBD7	3.24e-06	187	283	9	e93cad16a087d1443cbf4e1690dc1b35d7a84c41
ToppCell	droplet-Fat-SCAT-30m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM88 CRIM1 KIF26A MCAM MEOX2 NOTCH3 LAMA5 BCL6B TNS1	3.39e-06	188	283	9	5cf060bb8adaefa9964187195d67993c1248ef47
ToppCell	droplet-Fat-SCAT-30m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM88 CRIM1 KIF26A MCAM MEOX2 NOTCH3 LAMA5 BCL6B TNS1	3.39e-06	188	283	9	e901a9bdf00b8e91806f445af66647373bf62661
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM88 CRIM1 KIF26A PLXND1 TNFRSF10B MEOX2 VWF BCL6B TNS1	3.39e-06	188	283	9	05de6677f9bb4b00fed47f4b72f4a2cd507cb0f2
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CRIM1 OBSCN MCAM ARHGEF17 STARD9 CACNA1H NOTCH3 GRID1 TNS1	3.39e-06	188	283	9	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	droplet-Fat-SCAT-30m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM88 CRIM1 KIF26A MCAM MEOX2 NOTCH3 LAMA5 BCL6B TNS1	3.39e-06	188	283	9	449f9602df3c83b2110eb479a00d428d1b55b423
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_Krt80\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCERG1L KIF26A OBSCN SEBOX CACNA1H PAPLN PIK3R6 TNS1	3.41e-06	141	283	8	40ef6d792e11fe10963d64eb0b606b90556c1a70
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CRIM1 ARHGEF17 CACNA1H NOTCH3 GRID1 ROBO2 ADAM33 LGR6 SH3RF3	3.54e-06	189	283	9	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CRIM1 ARHGEF17 CACNA1H NOTCH3 GRID1 ROBO2 ADAM33 LGR6 SH3RF3	3.54e-06	189	283	9	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CRIM1 AXL MCAM ARHGEF17 INKA2 NOTCH3 OAZ2 AOC3 AJUBA	3.69e-06	190	283	9	1004e89d99c9d46c78b7d3532d8d4aadb81a96fd
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CRIM1 OBSCN MCAM ARHGEF17 STARD9 CACNA1H NOTCH3 GRID1 TNS1	3.69e-06	190	283	9	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CRIM1 OBSCN MCAM ARHGEF17 STARD9 CACNA1H NOTCH3 GRID1 TNS1	3.69e-06	190	283	9	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CRIM1 AXL MCAM ARHGEF17 INKA2 NOTCH3 OAZ2 AOC3 AJUBA	3.69e-06	190	283	9	10b02c62e72bfea9767e3e751011436925da823e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CRIM1 OBSCN ARHGEF17 INKA2 STARD9 CACNA1H NOTCH3 AOC3 TNS1	3.85e-06	191	283	9	1626b23a57429f835fddc052e3c57f63a4e5b8bb
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CRIM1 OBSCN ARHGEF17 INKA2 STARD9 CACNA1H NOTCH3 AOC3 TNS1	3.85e-06	191	283	9	716dfa7fccbd62b5f574792e68a26dc6c45511dc
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM88 GATM PLXND1 ARHGEF17 RAB3IL1 PCDHB15 OAZ2 LGR6 TNS1	4.02e-06	192	283	9	6806a1a9fe00395dc1abc3e0124b4261dc701f31
ToppCell	PCW_05-06-Endothelial-Endothelial_immature-endo_immature1_(0)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TMEM88 SP100 GATA3 TNFRSF10A VWF MMP28 BCL6B PIK3R6 SH3RF3	4.20e-06	193	283	9	2661ad9107ed9231e4afea4442a79051139a31df
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HGFAC SYTL2 FCGBP SEC16A CACNA1H MLPH LGALS12 CREB3L4 SHROOM1	4.20e-06	193	283	9	6a9bce5064938b5b84ad57b4fd4a7841afe100c8
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CRIM1 AXL MCAM ARHGEF17 INKA2 NOTCH3 AOC3 ADAM33 AJUBA	4.38e-06	194	283	9	6a4e7f1bf67bad94cd8c472e7c66798b0c25ba01
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1A AXL MCAM ARHGEF17 NOTCH3 TACC2 AOC3 ADAM33 TNS1	4.38e-06	194	283	9	aaecde88bd54134a938e76cdf059c1c2653e4e77
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRIM1 AXL ARHGEF17 NOTCH3 SGCA LAMA5 NTN4 AOC3 AJUBA	4.38e-06	194	283	9	b35e33439b6d3b5d69147e617224d2c8fd056223
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	GATM NELL1 TMEM132A SGCA DOK7 TACC2 SIM1 ADGRA1 AJUBA	4.56e-06	195	283	9	80b973d2a23ef9b101c90e1635e68c9a3f78f65d
ToppCell	Fibroblasts-Pericytes\|Fibroblasts / lung cells shred on cell class, cell subclass, sample id	SYTL2 MCAM ARHGEF17 SYNE2 CACNA1H NOTCH3 LAMA5 OAZ2 TNS1	4.56e-06	195	283	9	c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	CRIM1 MCAM PRAG1 MAST4 CR1L SNED1 NTN4 ROBO2 SH3RF3	4.76e-06	196	283	9	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	CRIM1 SYTL2 MCAM CACNA1H NOTCH3 SGCA LAMA5 AOC3 LGR6	4.76e-06	196	283	9	541b1fcf509e362f6f48720046cb5378aaf7c591
ToppCell	Bronchial_Biopsy-Mesenchymal-Smooth_muscle\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	CRIM1 KIF26A MCAM CACNA1H NOTCH3 VWF SGCA TRIM3 TMEM102	4.96e-06	197	283	9	98f0184a09563a544f0c2d4df22c9db2fbc95019
ToppCell	distal-mesenchymal-Vascular_Smooth_Muscle\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CRIM1 SYTL2 MCAM MEOX2 NOTCH3 SGCA NTN4 AOC3 ADAM33	5.16e-06	198	283	9	8d1c74a728040386316fbdcabcdea5fb2b5a76a1
ToppCell	distal-mesenchymal-Vascular_Smooth_Muscle-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CRIM1 SYTL2 MCAM MEOX2 NOTCH3 SGCA NTN4 AOC3 ADAM33	5.16e-06	198	283	9	5080767ff55326b7d94fca27d398237c4a15c1ed
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Mucous\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FRMD6-AS1 GATM FCGBP MLPH EPM2A MUC5B CREB3L4 TSPAN10 WFIKKN1	5.16e-06	198	283	9	2ae9564da9913510141994262f3739eb095e0a68
ToppCell	normal_Lung-Fibroblasts-Smooth_muscle_cells\|Fibroblasts / Location, Cell class and cell subclass	CRIM1 SYTL2 MCAM NOTCH3 SGCA LAMA5 NTN4 LGR6 AJUBA	5.38e-06	199	283	9	d65847ceb68a560798df3f73e6f838e7c3e38a1c
ToppCell	mLN-(5)_Dendritic_cell-(54)_pDC\|mLN / shred on region, Cell_type, and subtype	MAP1A ULK1 MED26 SERPINF2 RAB3IL1 BAHCC1 SHROOM2 AR ICAM5	5.38e-06	199	283	9	1e738219784a446ee8b0ddeb408e0050e1929e60
ToppCell	mLN-Dendritic_cell-pDC\|mLN / Region, Cell class and subclass	MAP1A ULK1 MED26 SERPINF2 RAB3IL1 BAHCC1 SHROOM2 AR ICAM5	5.38e-06	199	283	9	54f1abb57af7bf8a8b82a38b933f257df3b5d8df
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLXND1 ZXDA SELE VWF MMP28 TRIM3 MMP25 BCL6B SNED1	5.38e-06	199	283	9	d95d78b2ebc9a20532466e4d4be579b4faf6776f
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLXND1 ZXDA SELE VWF MMP28 TRIM3 MMP25 BCL6B SNED1	5.38e-06	199	283	9	cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec
ToppCell	proximal-mesenchymal-Vascular_Smooth_Muscle-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CRIM1 SYTL2 MCAM NOTCH3 SGCA GRID1 NTN4 AOC3 ADAM33	5.60e-06	200	283	9	5c0135d3cb6f7fa904e9760904dfe5f11c7e9102
ToppCell	proximal-mesenchymal-Vascular_Smooth_Muscle\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CRIM1 SYTL2 MCAM NOTCH3 SGCA GRID1 NTN4 AOC3 ADAM33	5.60e-06	200	283	9	22892afca3666e944102c231b3f10340d8391364
ToppCell	proximal-3-mesenchymal-Vascular_Smooth_Muscle\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CRIM1 SYTL2 MCAM NOTCH3 SGCA GRID1 NTN4 AOC3 ADAM33	5.60e-06	200	283	9	870ab11343711f64fe6d6a858fc420fe17f1636a
ToppCell	(54)_pDC\|World / shred on Cell_type and subtype	MAP1A NELL1 ULK1 MED26 SERPINF2 RAB3IL1 BAHCC1 SHROOM2 AR	6.32e-06	203	283	9	b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	AXL SYTL2 MCAM MEOX2 CACNA1H NOTCH3 PCDHB14 LGR6	9.08e-06	161	283	8	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CRIM1 MCAM GATM KCNC4 CACNA1H NOTCH3 AOC3 LGR6	9.93e-06	163	283	8	51dee6c21cbeca4e17d1cc386e203f0c403089e8
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCAF6 MAP1A ZKSCAN5 NYAP2 PCDHGC4 TMEM121B BCL6B SLX4	9.93e-06	163	283	8	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	DCDC2B PLXND1 PCDHB14 GNPNAT1 E2F2 AR TRIM3	1.17e-05	120	283	7	eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1
ToppCell	control-Myeloid-pDC\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAP1A DBN1 HESX1 RECQL5 SERPINF2 COL9A3 TTC24 SH3RF3	1.24e-05	168	283	8	affc39c7568b7df4b36af6f5b0e3702a18b6268c
ToppCell	facs-Lung-nan-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRIM1 MCAM VWF MMP28 PCDHB15 MYOZ3 LAMB2 MICALL1	1.35e-05	170	283	8	67d7e1da3ebd2d14cb2e67799e94d655027ed5c4
ToppCell	facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRIM1 MCAM VWF MMP28 PCDHB15 MYOZ3 LAMB2 MICALL1	1.35e-05	170	283	8	8e1f757ed62218c0fb6525f49d142dd2cd29acf9
ToppCell	Healthy/Control-MAIT\|World / Disease group and Cell class	CFH SYTL2 GATA3 PER1 DBN1 SYNE2 NTN4 LRIG1	1.41e-05	171	283	8	61515114b17816a8f9ef6a57262eb9e977b6ede4
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CRIM1 AXL MCAM ARHGEF17 TONSL NOTCH3 OAZ2 AOC3	1.47e-05	172	283	8	03a0aff6b7971093a4347b5ed12546d78374c56f
ToppCell	Adult-Mesenchymal-pericyte_cell-D231\|Adult / Lineage, Cell type, age group and donor	HIC1 CRIM1 MCAM ARHGEF17 KCNC4 CACNA1H NOTCH3 SH3RF3	1.47e-05	172	283	8	858cee96c1c06160863b4adcd7023c0d678bd50f
ToppCell	Healthy/Control-MAIT\|Healthy/Control / Disease group and Cell class	CFH SYTL2 MCAM PER1 DBN1 SYNE2 NTN4 LRIG1	1.53e-05	173	283	8	56247c1e07477a8922fe2e3950ae05e2217fd77c
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CRIM1 AXL MCAM MFRP ARHGEF17 NOTCH3 AJUBA TNS1	1.53e-05	173	283	8	f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a
Computational	Ovary genes.	CFH CRIM1 PER1 GATM PLXND1 TNFRSF10B DBN1 PTPRK PKD1 ULK1 NOTCH3 SELE VWF LAMB2 AR AOC3 TNFRSF13B	1.42e-05	368	150	17	MODULE_1
Drug	Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	NAB2 PER1 KDM6B RIN2 RECQL5 CACNA1H NOTCH3 BTBD7 MARK4 SORBS3 TJAP1 TRAPPC14 AGRN	9.91e-07	197	278	13	3484_UP
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A	SOX3 ZSWIM8 CEBPA RNF19B PLXND1 DBN1 MAST4 WDR62 ZNF576 LRIG1 BTBD7 AGRN	5.34e-06	195	278	12	7239_DN
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A	CYP4F8 KREMEN2 PER1 DBN1 ARHGEF17 MAP3K12 CACNA1H KAZALD1 WDR62 BAHCC1 LRIG1 MARK4	5.34e-06	195	278	12	4706_DN
Drug	Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A	TTLL5 NAB2 RNF19B PER1 ZC3H3 TAOK2 PRRG4 KAZALD1 RAB3IL1 WDR62 TBC1D17 TJAP1	5.63e-06	196	278	12	2815_UP
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	DLG5 RNF19B PLXND1 ARHGEF17 INKA2 TAOK2 MAST4 KAZALD1 NOTCH3 WDR62 EPM2A PSD4	5.63e-06	196	278	12	5438_DN
Drug	Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; MCF7; HT_HG-U133A	CRIM1 KREMEN2 DELE1 MAP3K12 INKA2 TAOK2 MAST4 PRRG4 POLG ZNF576 SORBS3 TRAPPC14	5.93e-06	197	278	12	7009_UP
Drug	(-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DLG5 TTLL5 PLXND1 TNFRSF10B MAP3K12 ZKSCAN5 TECPR2 PRRG4 LAMA5 ZNF576 AR MARK4	6.57e-06	199	278	12	3531_DN
Drug	chromium oxide	PER1 NSUN2 RAB3IL1 MGAM	1.43e-05	13	278	4	CID000517276
Drug	Tribenoside [10310-32-4]; Up 200; 8.4uM; HL60; HT_HG-U133A	HGFAC AXL RAB3IL1 MGAM INPP5E TRIOBP CR1 TBC1D17 MICALL1 TJAP1 TNS1	1.73e-05	184	278	11	2946_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	NRIP1 ZSWIM8 CEBPA RNF19B SYTL2 KDM6B MAP3K12 MAST4 DBNDD1 BCL2L11 TRAPPC14	2.57e-05	192	278	11	5222_DN
Drug	Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A	ZSWIM8 SP100 ARHGEF17 ZC3H3 ZKSCAN5 KAZALD1 NOTCH3 POLG DLGAP4 TRAPPC14 CCDC9	2.83e-05	194	278	11	5362_UP
Drug	SC-560; Down 200; 10uM; MCF7; HT_HG-U133A	SP100 TTLL5 NAB2 PLXND1 MAST4 RECQL5 KAZALD1 ZNF576 IL17RC TRIM3 TJAP1	2.96e-05	195	278	11	6870_DN
Drug	Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; MCF7; HT_HG-U133A	SP100 CEBPA NAB2 MAP3K12 ZKSCAN5 PRRG4 BTBD7 MARK4 LRP3 TRAPPC14 PSD4	3.11e-05	196	278	11	3533_DN
Drug	Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A	KREMEN2 TTLL5 NAB2 TNFRSF10B CACNA1H PRRG4 KAZALD1 NOTCH3 PLXNA3 GREB1 TRAPPC14	3.11e-05	196	278	11	3567_DN
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A	KDM6B TAOK2 RAB3IL1 POLG DLGAP4 ZNF576 IL17RC TBC1D17 SORBS3 AGRN PSD4	3.11e-05	196	278	11	4227_DN
Drug	Glibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A	SP100 CEBPA CRIM1 NAB2 DELE1 CAMTA2 MAP3K12 TAOK2 KDM6A EPM2A INPP5E	3.25e-05	197	278	11	7202_DN
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A	CEBPA KREMEN2 TAOK2 CACNA1H KDM6A POLG SH2D3A TRIOBP IL17RC TRIM3 MARK4	3.25e-05	197	278	11	4761_DN
Drug	Propylthiouracil [51-52-5]; Down 200; 23.4uM; MCF7; HT_HG-U133A	SP100 KDM6B ZC3H3 MAP3K12 RBM25 KAZALD1 EPM2A EP400 TRIM3 BTBD7 LRP3	3.25e-05	197	278	11	2837_DN
Drug	Flurandrenolide [1524-88-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A	DBN1 CACNA1H KDM6A ABTB2 WDR62 IL17RC LRIG1 BTBD7 MARK4 GREB1 CCDC9	3.25e-05	197	278	11	4702_DN
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A	MAP1A TTLL5 RNF19B PER1 TNFRSF10B NOTCH3 WDR62 BAHCC1 DLGAP4 LRP3 AGRN	3.25e-05	197	278	11	4295_DN
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A	CEBPA SYTL2 GATA3 TAOK2 DBNDD1 KAZALD1 SEMA4F MYOZ3 IL17RC ZNF592 BTBD7	3.25e-05	197	278	11	6863_UP
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	CAMTA2 RAB3IL1 POLG SH2D3A TRIOBP LAMB2 MICALL1 BTBD7 MARK4 GREB1 TRAPPC14	3.25e-05	197	278	11	7440_DN
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	PLXND1 TNFRSF10B ARHGEF17 TAOK2 CACNA1H RAB3IL1 BAHCC1 POLG IL17RC MICALL1 MARK4	3.25e-05	197	278	11	3877_DN
Drug	Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A	CEBPA CAMTA2 PLXND1 ZC3H3 MAP3K12 TAOK2 DBNDD1 MYOZ3 MARK4 SORBS3 PSD4	3.41e-05	198	278	11	4498_DN
Drug	Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; MCF7; HT_HG-U133A	NAB2 RNF19B ZC3H3 INKA2 PRRG4 EPM2A IL17RC CR1 ATP10D MARK4 LRP3	3.41e-05	198	278	11	5452_DN
Drug	Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A	MAP1A PER1 ARHGEF17 CACNA1H KAZALD1 RAB3IL1 DLGAP4 MYOZ3 IL17RC CR1 TJAP1	3.41e-05	198	278	11	1519_UP
Drug	Butacaine [149-16-6]; Up 200; 13uM; MCF7; HT_HG-U133A	SOX3 NAB2 RNF19B RECQL5 CACNA1H NOTCH3 BCL2L11 CR1 ATP10D TRAPPC14 CLCF1	3.41e-05	198	278	11	3469_UP
Drug	Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A	CEBPA TTLL5 NAB2 TNFRSF10B INKA2 KAZALD1 BAHCC1 SEMA4F MMP25 BTBD7 CLCF1	3.41e-05	198	278	11	2647_DN
Drug	Piperacetazine [3819-00-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	CAMTA2 DBN1 KDM6B ARHGEF17 TAOK2 CACNA1H TRMT13 KAZALD1 RAB3IL1 NOTCH3 TRAPPC14	3.57e-05	199	278	11	3574_DN
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SP100 RNF19B TNFRSF10B MAP3K12 CACNA1H WDR62 TRIOBP MARK4 SORBS3 GREB1 PSD4	3.57e-05	199	278	11	6458_DN
Drug	Tocainide hydrochloride; Up 200; 17.4uM; HL60; HT_HG-U133A	MCAM GATM TAOK2 PHF1 NFATC1 KAZALD1 PLXNA3 SEMA4F TRIM3 TNS1 CLCF1	3.57e-05	199	278	11	2931_UP
Drug	Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SP100 TTLL5 DBN1 ZC3H3 RAB3IL1 WDR62 BCL2L11 DLGAP4 TRIM3 SORBS3 TRAPPC14	3.57e-05	199	278	11	7330_DN
Drug	Moxonidine [75438-57-2]; Down 200; 16.6uM; MCF7; HT_HG-U133A	SUSD6 KREMEN2 TTLL5 PER1 MAST4 KDM6A WDR62 POLG SH2D3A TBC1D17 CLCF1	3.57e-05	199	278	11	7343_DN
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A	DLG5 KREMEN2 ARHGEF17 MAST4 RECQL5 KAZALD1 WDR62 BAHCC1 PLXNA3 TBC1D17 PSD4	3.57e-05	199	278	11	5601_DN
Drug	Suxibuzone [27470-51-5]; Down 200; 9.2uM; HL60; HT_HG-U133A	TTLL5 ZKSCAN5 TECPR2 RECQL5 MLPH INPP5E CR1 TBL3 TBC1D17 TJAP1 CLCF1	3.57e-05	199	278	11	2503_DN
Drug	Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A	SOX3 NAB2 DELE1 KDM6B MAST4 KAZALD1 ABTB2 SEMA4F LAMA5 ZNF576 LRIG1	3.74e-05	200	278	11	3577_DN
Drug	trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A	NRIP1 SP100 GATA3 MCAM KAZALD1 POLG ZNF576 MICALL1 GREB1 PSD4	7.39e-05	179	278	10	332_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	NRIP1 SYTL2 MAP3K12 MAST4 DBNDD1 BAHCC1 PLXNA3 TRIM3 GREB1 AGRN	1.16e-04	189	278	10	5578_DN
Drug	genistein; Up 200; 10uM; HL60; HT_HG-U133A	CYP4F8 AXL GATA3 MAP3K12 TECPR2 ABTB2 COL9A3 CR1 TRIM3 SNED1	1.16e-04	189	278	10	2695_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	NRIP1 ZSWIM8 SYTL2 PLXND1 KDM6B BCL2L11 INPP5E TRIOBP LAMA5 ZNF592	1.32e-04	192	278	10	6986_DN
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A	NAB2 SYTL2 DBNDD1 PRRG4 KAZALD1 ULK1 RAB3IL1 BAHCC1 SORBS3 TRAPPC14	1.38e-04	193	278	10	5588_DN
Drug	Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RNF19B PER1 MAST4 NOTCH3 EPM2A MYOZ3 SORBS3 TJAP1 GREB1 CLCF1	1.38e-04	193	278	10	2894_DN
Drug	Iopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A	DLG5 CAMTA2 ARHGEF17 MAP3K12 ZKSCAN5 MAST4 RIN2 CR1 MARK4 CLCF1	1.44e-04	194	278	10	5448_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A	CACNA1H RAB3IL1 WDR62 BAHCC1 EPM2A DLGAP4 TRIM3 TJAP1 GREB1 TNS1	1.44e-04	194	278	10	4738_DN
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; PC3; HT_HG-U133A	CFH CEBPA PER1 RGS9 MAP3K12 SEMA4F MYOZ3 TRIM3 MMP25 TNFRSF13B	1.44e-04	194	278	10	3785_UP
Drug	Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A	SP100 CRIM1 TAOK2 RIN2 PLXNA3 POLG TRIM3 MARK4 GREB1 TRAPPC14	1.44e-04	194	278	10	3303_DN
Drug	Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A	KREMEN2 TTLL5 TNFRSF10B MAST4 RIN2 RECQL5 PRRG4 MYOZ3 CLCF1 AGRN	1.44e-04	194	278	10	2864_DN
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	SOX3 ZNF142 CRIM1 NAB2 RNF19B DELE1 PLXND1 BCL2L11 GREB1 TRAPPC14	1.44e-04	194	278	10	7446_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	SOX3 ZSWIM8 CEBPA SYTL2 CAMTA2 PLXND1 KDM6B EP400 BCL2L11 SH2D3A	1.50e-04	195	278	10	6979_DN
Drug	Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A	PER1 PLXND1 TAOK2 MAST4 RIN2 CACNA1H KDM6A BAHCC1 LRIG1 TRAPPC14	1.50e-04	195	278	10	2264_DN
Drug	prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A	KREMEN2 RNF19B RGS9 TNFRSF10B ZKSCAN5 CACNA1H RAB3IL1 TRIM3 TBC1D17 TRAPPC14	1.50e-04	195	278	10	6552_DN
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A	SP100 MAP1A MCAM PER1 PHF1 WDR62 DLGAP4 SNED1 ZNF592 AGRN	1.50e-04	195	278	10	4124_UP
Drug	Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A	KIF21B HGFAC NAB2 INKA2 RECQL5 RAB3IL1 MGAM EPM2A TJAP1 AGRN	1.56e-04	196	278	10	3420_UP
Drug	Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A	NAB2 RNF19B MCAM TAOK2 CACNA1H KAZALD1 COL9A3 DLGAP4 TBC1D17 CCDC9	1.56e-04	196	278	10	2793_UP
Drug	Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	SP100 TTLL5 GATA3 PLXND1 MAST4 KAZALD1 BAHCC1 POLG LRP3 TNS1	1.56e-04	196	278	10	4594_DN
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; HL60; HT_HG-U133A	HGFAC DLG5 NAB2 DBNDD1 NFATC1 BAHCC1 PLXNA3 SEMA4F DLGAP4 MMP25	1.56e-04	196	278	10	2207_UP
Drug	Pempidine tartrate [546-48-5]; Up 200; 13uM; PC3; HT_HG-U133A	KIF21B ZSWIM8 CEBPA PER1 ARHGEF17 NOTCH3 CBS TRIM3 TRAF3IP3 AGRN	1.56e-04	196	278	10	4307_UP
Drug	Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A	DELE1 TNFRSF10B INKA2 TAOK2 MAST4 RIN2 EPM2A CR1 ATP10D SORBS3	1.56e-04	196	278	10	5446_DN
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	TTLL5 NAB2 KDM6B TAOK2 IL17RC LETM1 TBC1D17 TRAPPC14 TNS1 PSD4	1.56e-04	196	278	10	6203_DN
Drug	Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; PC3; HT_HG-U133A	SYTL2 MAST4 TRIOBP MUC5B IL17RC RAB11FIP1 LETM1 TRIM3 SORBS3 CLCF1	1.56e-04	196	278	10	7256_DN
Drug	Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; HL60; HG-U133A	ZSWIM8 RNF19B GATA3 GOT2 CR1 CSF3R ICAM5 TNFRSF13B OLIG2 CLCF1	1.63e-04	197	278	10	1564_UP
Drug	PHA-00665752 [477575-56-7]; Up 200; 10uM; MCF7; HT_HG-U133A	KREMEN2 MCAM PER1 TNFRSF10B MAP3K12 ZKSCAN5 BAHCC1 MUC5B MARK4 TRAPPC14	1.63e-04	197	278	10	6578_UP
Drug	Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A	KIF21B ZSWIM8 MAP1A TTLL5 INKA2 RECQL5 CACNA1H PLXNA3 MARK4 LRP3	1.63e-04	197	278	10	5252_UP
Drug	aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A	SP100 RNF19B RAB3IL1 POLG TRIM3 TBC1D17 BTBD7 MARK4 TRAPPC14 PSD4	1.63e-04	197	278	10	1204_UP
Drug	Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A	MAP1A ARHGEF17 TAOK2 PLXNA3 POLG TRIM3 TBC1D17 MARK4 SORBS3 PSD4	1.63e-04	197	278	10	3411_UP
Drug	Vigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A	ZSWIM8 PER1 TNFRSF10B DBN1 KAZALD1 WDR62 BCL2L11 MYOZ3 TBC1D17 PSD4	1.63e-04	197	278	10	5415_DN
Drug	Esculetin [305-01-1]; Up 200; 22.4uM; HL60; HT_HG-U133A	ZSWIM8 HESX1 PHF1 NFATC1 RECQL5 SEMA4F IL17RC TRIM3 TBC1D17 CLCF1	1.63e-04	197	278	10	3120_UP
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	MAP1A KREMEN2 TTLL5 MAP3K12 MAST4 TECPR2 CACNA1H BAHCC1 TJAP1 CLCF1	1.63e-04	197	278	10	7500_UP
Drug	PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A	MAP1A SYTL2 KDM6B MAP3K12 TMEM132A KAZALD1 ABTB2 BTBD7 MARK4 SORBS3	1.63e-04	197	278	10	7390_DN
Drug	Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; PC3; HT_HG-U133A	TTLL5 NAB2 KDM6B DBNDD1 RECQL5 SEMA4F BTBD7 AOC3 TNS1 CCDC9	1.63e-04	197	278	10	4620_UP
Drug	Furosemide [54-31-9]; Down 200; 12uM; PC3; HT_HG-U133A	CEBPA MAP1A NAB2 PHF1 DBNDD1 TMEM132A SEMA4F MUC5B MARK4 TRAPPC14	1.63e-04	197	278	10	4503_DN
Drug	Estrone [53-16-7]; Down 200; 14.8uM; HL60; HT_HG-U133A	TTLL5 NAB2 DBN1 KDM6B ZC3H3 NFATC1 RECQL5 BAHCC1 BCL2L11 DLGAP4	1.63e-04	197	278	10	3071_DN
Drug	(R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A	KREMEN2 ARHGEF17 ZKSCAN5 PRRG4 KAZALD1 BAHCC1 DLGAP4 IL17RC TRIM3 SORBS3	1.70e-04	198	278	10	6096_DN
Drug	Enalapril maleate [76095-16-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A	CRIM1 RNF19B PLXND1 ZC3H3 KAZALD1 RAB3IL1 PLXNA3 BCL2L11 TBC1D17 AGRN	1.70e-04	198	278	10	7428_DN
Drug	Meticrane [1084-65-7]; Up 200; 14.6uM; MCF7; HT_HG-U133A	ARHGEF17 ZC3H3 TAOK2 PHF1 NOTCH3 BAHCC1 FAM149A MYOZ3 IL17RC MARK4	1.70e-04	198	278	10	5984_UP
Drug	Idazoxan hydrochloride [79944-56-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A	KREMEN2 INKA2 TAOK2 MAST4 RECQL5 KDM6A WDR62 POLG LAMB2 MARK4	1.70e-04	198	278	10	5347_UP
Drug	Sulfasalazine [599-79-1]; Up 200; 10uM; PC3; HT_HG-U133A	RNF19B GATA3 DBNDD1 RECQL5 KAZALD1 ULK1 NOTCH3 WDR62 E2F2 TBC1D17	1.70e-04	198	278	10	6346_UP
Drug	Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	DLG5 ZC3H3 ZKSCAN5 INKA2 CACNA1H BAHCC1 TRIM3 BTBD7 SORBS3 TRAPPC14	1.70e-04	198	278	10	3617_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	CEBPA NAB2 KDM6B HCFC2 WDR62 SEMA4F LAMA5 LRIG1 ZNF592 PSD4	1.70e-04	198	278	10	7003_DN
Drug	Sulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A	ZSWIM8 KREMEN2 DELE1 CAMTA2 TAOK2 MAST4 RECQL5 WDR62 EPM2A MARK4	1.70e-04	198	278	10	6799_UP
Drug	Cefaclor [70356-03-5]; Down 200; 10.4uM; PC3; HT_HG-U133A	TTLL5 TAOK2 DBNDD1 TECPR2 KAZALD1 WDR62 POLG MICALL1 TJAP1 TNS1	1.70e-04	198	278	10	6622_DN
Drug	quercetin dihydrate; Down 200; 1uM; MCF7; HT_HG-U133A_EA	CEBPA RNF19B DELE1 UBE2D1 MAST4 TECPR2 EPM2A POLG DLGAP4 BTBD7	1.70e-04	198	278	10	917_DN
Drug	cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; MCF7; HT_HG-U133A_EA	ZSWIM8 SP100 CEBPA CRIM1 RNF19B DELE1 PLXND1 PHF1 RECQL5 KDM6A	1.70e-04	198	278	10	881_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	TTLL5 PER1 DELE1 CAMTA2 TNFRSF10B KDM6B ZC3H3 ABTB2 SEMA4F CCDC9	1.70e-04	198	278	10	1650_DN
Drug	Sulfachloropyridazine [80-32-0]; Down 200; 14uM; HL60; HT_HG-U133A	CRIM1 RECQL5 RAB3IL1 BCL2L11 TRIOBP BTBD7 MARK4 CLCF1 AGRN CCDC9	1.70e-04	198	278	10	2191_DN
Drug	Salbutamol [18559-94-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	SOX3 SP100 KREMEN2 NAB2 PER1 TNFRSF10B KDM6B ARHGEF17 UBE2D1 TRIM3	1.77e-04	199	278	10	4700_DN
Drug	Cinoxacin [28657-80-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A	SP100 CAMTA2 KDM6B ZC3H3 MAST4 DLGAP4 TRIOBP AR ZNF592 TRAPPC14	1.77e-04	199	278	10	3463_DN
Drug	Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A	MYT1L PER1 ARHGEF17 ZKSCAN5 TAOK2 WDR62 COL9A3 GREB1 TNS1 PSD4	1.77e-04	199	278	10	6489_UP
Drug	Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A	ZSWIM8 SP100 SPINK2 TTLL5 RNF19B MCAM MEOX2 RECQL5 DLGAP4 MMP25	1.77e-04	199	278	10	3546_UP
Drug	Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A	KREMEN2 NAB2 KDM6B MICALL1 MARK4 SORBS3 TRAPPC14 EDEM1 AGRN CCDC9	1.77e-04	199	278	10	3435_DN
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; HL60; HT_HG-U133A	MAP1A TNFRSF10B RAB3IL1 BCL2L11 LAMB2 CR1 MMP25 MARK4 SORBS3 CCDC9	1.77e-04	199	278	10	2386_DN
Drug	Bethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A	CEBPA KREMEN2 CAMTA2 DBN1 ZKSCAN5 RECQL5 HCFC2 EPM2A DLGAP4 MICALL1	1.77e-04	199	278	10	5539_DN
Drug	Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; MCF7; HT_HG-U133A	RNF19B KDM6B MAP3K12 RECQL5 KAZALD1 ABTB2 ZNF576 LETM1 TBC1D17 GREB1	1.77e-04	199	278	10	2756_DN
Drug	Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; PC3; HT_HG-U133A	SP100 CAMTA2 ZKSCAN5 TECPR2 RECQL5 BAHCC1 MARK4 TJAP1 TRAPPC14 TNS1	1.84e-04	200	278	10	6676_DN
Drug	PHA-00846566E [724718-26-7]; Down 200; 10uM; MCF7; HT_HG-U133A	DLG5 RNF19B PLXND1 MAP3K12 RBM25 UBE2D1 PRRG4 RAB3IL1 ZNF576 TRAPPC14	1.84e-04	200	278	10	7081_DN
Drug	Strophanthidin [66-28-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	SOX3 ZSWIM8 KREMEN2 TTLL5 RECQL5 TRMT13 RAB3IL1 EPM2A MICALL1 SORBS3	1.84e-04	200	278	10	7182_DN
Drug	Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; HL60; HT_HG-U133A	MCAM GATM PLXND1 HESX1 RECQL5 SYNE2 KAZALD1 LETM1 TNS1 CLCF1	1.84e-04	200	278	10	3127_UP
Drug	potassium bromide	TONSL MGAM TRIOBP CR1L REXO2	2.38e-04	46	278	5	CID000253877
Disease	serum alanine aminotransferase measurement	CFH HGFAC NRIP1 DLG5 CRIM1 IRAK1 TNFRSF10B PRAG1 RECQL4 SLC30A10 NYAP2 MMP28 HECTD4 FBXL17 LAMA5 PKD2L1 CDCP2 IQCN ATP10D MMP25 ZNF517 MARK4 ADGRA1	3.61e-06	869	262	23	EFO_0004735
Disease	Age related macular degeneration	CFH HIC1 ABCA4 TNFRSF10A RLBP1	6.31e-06	30	262	5	C0242383
Disease	age at menopause	TNRC18 NOBOX SELE MGAM NYAP2 BCL2L11 POLG FBXL17 LGALS12 RLBP1 SH3PXD2B CSF3R	1.85e-05	302	262	12	EFO_0004704
Disease	Malignant neoplasm of breast	NRIP1 HIC1 ABCA4 OBSCN GATA3 PER1 DBN1 SYNE2 NOTCH3 VWF PCDHB15 SH2D3A TACC2 SIM1 SHROOM2 MAMDC4 AR EPG5 MICALL1 ICAM5 SLC6A5 ADAM33 LGR6 TNS1	3.58e-05	1074	262	24	C0006142
Disease	platelet crit	HGFAC NRIP1 HIC1 CEBPA MAP1A SUSD6 KIF26A SLC38A9 MCAM KDM6B MAST4 LINC00574 PRRG4 NOTCH3 NYAP2 VWF LAMA5 LMOD2 EPG5 TADA2B MARK4 TNFRSF13B	4.68e-05	952	262	22	EFO_0007985
Disease	Hodgkins lymphoma	GATA3 FCGBP PTPRK SERPINF2 CDCP2 ESYT3	9.22e-05	82	262	6	EFO_0000183
Disease	monocyte count	NRIP1 SP100 ZNF777 CEBPA SPINK2 SLC38A9 ARHGAP30 TNFRSF10B TNFRSF10A PKD1 LINC00574 SELE NYAP2 BCL2L11 TMEM121B PKD2L1 IQCN LCT ZFYVE28 TGIF1 CD1B CSF3R TADA2B MARK4 TNFRSF13B FCRL4	1.34e-04	1320	262	26	EFO_0005091
Disease	cortical thickness	VWA5B2 ABCA4 CTTNBP2 CRIM1 PLXND1 NELL1 DMRT3 MAST4 PKD1 TACC3 RNF32-DT NYAP2 INPP5E ESPNL TRIOBP LGALS12 TACC2 MICALL1 SH3PXD2B TSPAN10 ROBO2 TNS1 SH3RF3	1.66e-04	1113	262	23	EFO_0004840
Disease	lateral ventricle volume measurement	ABTB2 TRIOBP ROBO2 OLIG2	2.03e-04	33	262	4	EFO_0008487
Disease	Congenital myasthenic syndrome ib	DOK7 AGRN	2.34e-04	3	262	2	C1850792
Disease	glycosyl ceramide (d16:1/24:1, d18:1/22:1) measurement	SYNE2 ATP10D	2.34e-04	3	262	2	EFO_0800530
Disease	monocyte percentage of leukocytes	NRIP1 CEBPA ARHGAP30 TNFRSF10B KDM6B SEC16A BAHCC1 SELE NYAP2 BCL2L11 INPP5E E2F2 TGIF1 CSF3R TADA2B MARK4 TNFRSF13B	3.19e-04	731	262	17	EFO_0007989
Disease	sphingolipid measurement	SYNE2 RAB3IL1 DOK7 ATP10D	4.32e-04	40	262	4	EFO_0004622
Disease	reticulocyte count	SPINK2 RGS9 NELL1 SYNE2 PKD1 TMC8 LINC00574 USP4 SLC30A10 NYAP2 VWF BCL2L11 MMP28 GRAMD1A HECTD4 E2F2 AR MARK4 TNFRSF13B ADAM33 TNS1	4.61e-04	1045	262	21	EFO_0007986
Disease	response to anti-thyroid drug	RGS9 MMP25	4.66e-04	4	262	2	EFO_0007838
Disease	toll-like receptor 2 measurement	CFH TRIM3	4.66e-04	4	262	2	EFO_0020777
Disease	netrin-4 measurement	CFH NTN4	4.66e-04	4	262	2	EFO_0020592
Disease	reticulocyte measurement	CEBPA SPINK2 PER1 RGS9 KDM6B RBM25 SYNE2 TMC8 LINC00574 USP4 RAB3IL1 SLC30A10 NYAP2 VWF MMP28 GRAMD1A HECTD4 E2F2 AR MARK4 TNS1	5.09e-04	1053	262	21	EFO_0010700
Disease	BMI-adjusted waist-hip ratio, sex interaction measurement	PLXND1 NYAP2 GNPNAT1 SIM1	5.71e-04	43	262	4	EFO_0007788, EFO_0008343
Disease	serum gamma-glutamyl transferase measurement	HGFAC DLG5 MAP1A AXL IRAK1 TNFRSF10B TNFRSF10A RBM25 PKD1 ULK1 RAB3IL1 BAHCC1 NYAP2 FAM53A HECTD4 TRIOBP E2F2 SH3PXD2B GPBP1L1	5.73e-04	914	262	19	EFO_0004532
Disease	Colorectal Carcinoma	ABCA4 TCERG1L OBSCN PER1 KRT73 NELL1 HOXC9 NFATC1 KDM6A VPS18 CAD GRID1 ITPRID1 ICAM5 TRAF3IP3 LGR6	5.92e-04	702	262	16	C0009402
Disease	total blood protein measurement	CFH HGFAC ZSWIM8 CRIM1 PKD1 SEC16A LINC00574 USP4 NYAP2 INPP5E MARK4 TNFRSF13B	7.41e-04	449	262	12	EFO_0004536
Disease	fibroblast growth factor receptor 3 measurement	CFH TACC3	7.72e-04	5	262	2	EFO_0020390
Disease	syntaxin-1a measurement	CFH HGFAC	7.72e-04	5	262	2	EFO_0020759
Disease	osteoarthritis (biomarker_via_orthology)	TNFRSF10B TNFRSF10A NFATC1	8.18e-04	21	262	3	DOID:8398 (biomarker_via_orthology)
Disease	cortical surface area measurement	TMEM88 CTTNBP2 SPINK2 PLXND1 NELL1 DMRT3 MAST4 PKD1 LINC00574 TACC3 RNF32-DT NYAP2 CHRDL2 SGCA INPP5E TRIOBP FBXL17 LGALS12 NTN4 LRIG1 ROBO2 AJUBA TNS1 SH3RF3	9.81e-04	1345	262	24	EFO_0010736
Disease	diglyceride measurement	RAB3IL1 DOK7 PKD2L1 MARK4	1.09e-03	51	262	4	EFO_0010223
Disease	Eye Diseases, Hereditary	INPP5E RLBP1	1.15e-03	6	262	2	C0015398
Disease	ventral hernia	SLC30A10 TNS1	1.15e-03	6	262	2	EFO_1001866
Disease	stearoyl sphingomyelin (d18:1/18:0) measurement	CAMTA2 SYNE2	1.15e-03	6	262	2	EFO_0800611
Disease	Myasthenic Syndromes, Congenital	DOK7 LAMB2 AGRN	1.22e-03	24	262	3	C0751882
Disease	aspartate aminotransferase measurement	CFH KIF21B HGFAC DLG5 ABCA4 AXL OBSCN TNFRSF10B PRAG1 RAB3IL1 SLC30A10 ABTB2 GOT2 NYAP2 PYROXD2 HECTD4 PKD2L1 LCT	1.29e-03	904	262	18	EFO_0004736
Disease	alpha-linolenic acid measurement	RAB3IL1 DOK7 LCT	1.38e-03	25	262	3	EFO_0007759
Disease	sensory perception of bitter taste	MGAM ROBO2 SH3RF3	1.55e-03	26	262	3	GO_0050913
Disease	blood sedimentation	CR1 CR1L	1.60e-03	7	262	2	EFO_0004304
Disease	phosphatidylcholine 35:5 measurement	RAB3IL1 DOK7	1.60e-03	7	262	2	EFO_0021472
Disease	hepatocyte growth factor activator measurement	HGFAC DOK7	1.60e-03	7	262	2	EFO_0008152
Disease	glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement	SYNE2 ATP10D	1.60e-03	7	262	2	EFO_0800551
Disease	leukocyte immunoglobulin-like receptor subfamily A member 4 measurement	CFH BCL2L11	1.60e-03	7	262	2	EFO_0801765
Disease	mast/stem cell growth factor receptor kit measurement	CFH CEBPA	1.60e-03	7	262	2	EFO_0020554
Disease	Septo-Optic Dysplasia	SOX3 HESX1	1.60e-03	7	262	2	C0338503
Disease	lean mass-adjusted fat body mass, femoral neck bone mineral density	NFATC1 RIN2 GRID1	1.73e-03	27	262	3	EFO_0007785, EFO_0009890
Disease	myeloid white cell count	NRIP1 DLG5 SPINK2 SLC38A9 KMT2E ZKSCAN5 PKD1 SELE INPP5E GRAMD1A HECTD4 E2F2 LCT CBS CSF3R TADA2B MARK4 ADAM33	1.91e-03	937	262	18	EFO_0007988
Disease	eosinophil cationic protein measurement	CFH SPATA31C2	2.12e-03	8	262	2	EFO_0010913
Disease	cognitive disorder (biomarker_via_orthology)	IRAK1 DBN1	2.12e-03	8	262	2	DOID:1561 (biomarker_via_orthology)
Disease	tyrosine-protein kinase receptor TYRO3 measurement	CFH MGAM	2.12e-03	8	262	2	EFO_0020829
Disease	tumor necrosis factor receptor superfamily member 19L measurement	CFH ARHGEF17	2.12e-03	8	262	2	EFO_0008309
Disease	N2,N2-dimethylguanosine measurement	PYROXD2 SH3RF3	2.12e-03	8	262	2	EFO_0021125
Disease	intraocular pressure measurement	ABCA4 CTTNBP2 CAMTA2 MFRP LINC00574 KAZALD1 MLPH SLC30A10 TRIOBP FBXL17 TSPAN10 TNS1	2.13e-03	509	262	12	EFO_0004695
Disease	lysophosphatidylcholine measurement	RAB3IL1 MGAM DOK7 PKD2L1	2.26e-03	62	262	4	EFO_0010224
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	HGFAC NYAP2 REXO2 AGRN	2.40e-03	63	262	4	EFO_0022292
Disease	triacylglycerol 50:2 measurement	RNF32-DT NYAP2 PKD2L1	2.59e-03	31	262	3	EFO_0010409
Disease	phosphatidylcholine 39:5 measurement	RAB3IL1 DOK7	2.71e-03	9	262	2	EFO_0021476
Disease	level of Phosphatidylcholine (O-18:1_18:2) in blood serum	RAB3IL1 DOK7	2.71e-03	9	262	2	OBA_2045129
Disease	level of Phosphatidylcholine (16:0_20:5) in blood serum	RAB3IL1 DOK7	2.71e-03	9	262	2	OBA_2045077
Disease	level of Phosphatidylcholine (18:0_20:5) in blood serum	RAB3IL1 DOK7	2.71e-03	9	262	2	OBA_2045095
Disease	influenza A severity measurement	PRAG1 ZFYVE28	2.71e-03	9	262	2	EFO_0007743
Disease	glycosyl-N-stearoyl-sphingosine (d18:1/18:0) measurement	CREB3L4 ATP10D	2.71e-03	9	262	2	EFO_0800275
Disease	hearing loss	PTPRK COL9A3 TRIOBP GPBP1L1	3.00e-03	67	262	4	EFO_0004238
Disease	cyclic AMP-responsive element-binding protein 3-like protein 4 measurement	CFH CREB3L4	3.37e-03	10	262	2	EFO_0801506
Disease	bone morphogenetic protein 7 measurement	CFH CHRDL2	3.37e-03	10	262	2	EFO_0020187
Disease	cholesteryl ester 22:4 measurement	RAB3IL1 DOK7	3.37e-03	10	262	2	EFO_0021443
Disease	temporomandibular joint disorder	BAHCC1 SGCA	3.37e-03	10	262	2	EFO_0005279
Disease	decadienedioic acid (C10:2-DC) measurement	PKD2L1 PAPLN	3.37e-03	10	262	2	EFO_0800598
Disease	creatinine measurement	CFH KIF21B HGFAC HIC1 OBSCN GATM DBN1 NELL1 NFATC1 RNF32-DT NYAP2 FBXL17 LAMA5 SIM1 AR LRIG1 ZNF592 PSD4	3.61e-03	995	262	18	EFO_0004518
Disease	neuroblastoma	CRIM1 LAMA5 GRID1 MMP25 GREB1	3.83e-03	116	262	5	EFO_0000621
Disease	Cardiovascular Diseases	SELE VWF CBS	3.98e-03	36	262	3	C0007222
Disease	brain measurement, neuroimaging measurement	VWA5B2 KIF21B CTTNBP2 NELL1 MAST4 TACC3 RNF32-DT BAHCC1 TRIOBP ROBO2 TNS1 SH3RF3	3.98e-03	550	262	12	EFO_0004346, EFO_0004464
Disease	lysophosphatidylcholine 20:2 measurement	RAB3IL1 DOK7	4.10e-03	11	262	2	EFO_0021458
Disease	PR domain zinc finger protein 1 measurement	CFH USP4	4.10e-03	11	262	2	EFO_0801904
Disease	susceptibility to childhood ear infection measurement	MYT1L GATA3 USP4 RNF32-DT ICAM5 TNFRSF13B	4.35e-03	171	262	6	EFO_0007904
Disease	obsolete_red blood cell distribution width	NRIP1 SPINK2 MAST4 SYNE2 TMC8 USP4 SLC30A10 NYAP2 EP400 INPP5E HECTD4 PKD2L1 DUOX2 PAPLN E2F2 CR1L EPG5 RLBP1 ESYT3 LRIG1 MARK4 NUTM2F	4.60e-03	1347	262	22	EFO_0005192
Disease	Cooley's anemia	CACNA1H CAD	4.89e-03	12	262	2	C0002875
Disease	Thalassemia Minor	CACNA1H CAD	4.89e-03	12	262	2	C0085578
Disease	microphthalmia (implicated_via_orthology)	CRIM1 MFRP	4.89e-03	12	262	2	DOID:10629 (implicated_via_orthology)
Disease	beta Thalassemia	CACNA1H CAD	4.89e-03	12	262	2	C0005283
Disease	Thalassemia Intermedia	CACNA1H CAD	4.89e-03	12	262	2	C0271979
Disease	total iron binding capacity	HGFAC DOK7 DUOX2 GPBP1L1	5.18e-03	78	262	4	EFO_0006334
Disease	spondylosis	LINC00574 DOK7 PSD4	5.37e-03	40	262	3	MONDO_0002253
Disease	mean reticulocyte volume	CEBPA CRIM1 SPINK2 SUSD6 IRAK1 TONSL TACC3 CAD NYAP2 EP400 BCL2L11 E2F2 TGIF1 MARK4 TRAF3IP3	5.49e-03	799	262	15	EFO_0010701
Disease	level of Phosphatidylcholine (O-16:0_20:4) in blood serum	RAB3IL1 DOK7	5.74e-03	13	262	2	OBA_2045116
Disease	Connective Tissue Diseases	PKD1 COL9A3	5.74e-03	13	262	2	C0009782
Disease	hippocampal CA4 volume	MAST4 TMEM132A ITPRID1	5.75e-03	41	262	3	EFO_0009396
Disease	retinitis pigmentosa (is_implicated_in)	ABCA4 MFRP RLBP1	5.75e-03	41	262	3	DOID:10584 (is_implicated_in)
Disease	beverage consumption measurement	DELE1 NYAP2 SIM1 PSD4	6.45e-03	83	262	4	EFO_0010088
Disease	spleen volume	HIC1 NYAP2 HECTD4	6.57e-03	43	262	3	EFO_0600047
Disease	triacylglycerol 56:6 measurement	FCGBP RAB3IL1 DOK7	6.57e-03	43	262	3	EFO_0010433
Disease	autosomal dominant polycystic kidney disease (implicated_via_orthology)	PKD1 PKD2L1	6.66e-03	14	262	2	DOID:898 (implicated_via_orthology)
Disease	diacylglycerol 38:4 measurement	RAB3IL1 DOK7	6.66e-03	14	262	2	EFO_0020066
Disease	nodular sclerosis Hodgkin lymphoma	GATA3 PTPRK	6.66e-03	14	262	2	EFO_0004708
Disease	Impaired cognition	NOTCH3 CR1	6.66e-03	14	262	2	C0338656
Disease	FEV/FEC ratio	CTTNBP2 CRIM1 SPINK2 ARHGEF17 PHF1 FCGBP NFATC1 SYNE2 SLC30A10 RNF32-DT MGAM FBXL17 IL17RC FAM83H NTN4 TSPAN10 RNF38 ADAM33 AJUBA TNS1	6.98e-03	1228	262	20	EFO_0004713
Disease	hepatocyte growth factor measurement	HGFAC RNF32-DT DOK7	7.01e-03	44	262	3	EFO_0006903
Disease	neuroimaging measurement	VWA5B2 KIF21B CTTNBP2 PLXND1 TAOK2 NELL1 UBE2D1 DMRT3 MAST4 PKD1 TACC3 SLC4A9 BAHCC1 TACC2 CREB3L4 ROBO2 TNS1 SH3RF3	7.44e-03	1069	262	18	EFO_0004346
Disease	fibrinogen measurement, tissue plasminogen activator measurement	HGFAC PLXND1 HECTD4	7.46e-03	45	262	3	EFO_0004623, EFO_0004791
Disease	Alopecia, Male Pattern	TNFRSF10A AR	7.64e-03	15	262	2	C4083212
Disease	head and neck squamous cell carcinoma (is_implicated_in)	TNFRSF10B TNFRSF10A	7.64e-03	15	262	2	DOID:5520 (is_implicated_in)
Disease	unipolar depression, cognitive function measurement	DCAF6 SPINK2	7.64e-03	15	262	2	EFO_0003761, EFO_0008354
Disease	Androgenetic Alopecia	TNFRSF10A AR	7.64e-03	15	262	2	C0162311
Disease	Hemoglobin F Disease	CACNA1H CAD	7.64e-03	15	262	2	C0019025

Protein segments in the cluster

Peptide	Gene	Start	Entry
PLLGPSGPSCELHLA	MAMDC4	551	Q6UXC1
PCAPGAPSALGAQRT	ESYT3	6	A0FGR9
PGRLPAHSVACPSDL	EPM2A	231	B3EWF7
RICNHPGLVEPRHPG	EP400	1366	Q96L91
PCVGDSAVTPKVHPG	EPG5	111	Q9HCE0
ASLLPPPECTRQGGH	SLC4A9	601	Q96Q91
VEFARIHPPSSCPGD	BAHCC1	781	Q9P281
QPKGHGSRETPRCPA	BAHCC1	1626	Q9P281
GPHRLSIPSLTCNPD	AMOT	1036	Q4VCS5
HPGVLPEGATDLQCP	COL9A3	161	Q14050
ISCGELPIPPNGHRI	CSMD2	2656	Q7Z408
HPCLGPREKAGQTPQ	ABCA4	1301	P78363
PPGVCSRDPTPEQTH	SERPINF2	66	P08697
QRHGSPLPAGPCLFG	AJUBA	171	Q96IF1
HPCPLSGPLRLDGTA	CDCP2	421	Q5VXM1
PGPGESSHSICPAQV	FCRL4	431	Q96PJ5
LGPCQEAVAPSTHPT	AGRN	966	O00468
CPTQPGREAALGPGH	ADGRA1	496	Q86SQ6
TDLSRQEGHASPCPP	CCNI	356	Q14094
GGLTPTRHLAPQADP	CAMTA2	336	O94983
QALIHFGPACLSPPA	DPH2	101	Q9BQC3
EGDSCPHGSPQGPLA	BCL2L11	51	O43521
GPGSHPAPEACFQVV	ADAM33	531	Q9BZ11
QKRPCGHPGDTPFGT	CFH	81	P08603
CLQPHPFDPILASSG	DCAF6	766	Q58WW2
DIPDSPCSGGPIVSH	CDSN	221	Q15517
SGPSPGPGRLQLVCH	CD1B	211	P29016
CTPHPNSISIDAGPR	DLGAP4	736	Q9Y2H0
GSPALPGGCVPRNHF	ASTL	411	Q6HA08
PDPDPCARAGIHTSG	GRAMD1A	571	Q96CP6
PRAPSCRTVHNGPLG	ATP10D	496	Q9P241
DGGEPSQLPHCPSVS	AOC3	31	Q16853
EGGVHLLTPQPASCP	MUC5B	5621	Q9HC84
CGRSHAPQPPAHLGL	RNF32-DT	96	Q8NI28
PAVCPAAGHTLTPDR	RAB3IL1	201	Q8TBN0
NTPGDESPCGIIIPH	RBM25	636	P49756
PKCPAVSHGRVQPLG	RGS9	601	O75916
RCLAQPHPGTGVPRA	IQCN	581	Q9H0B3
GAPNSARATHNPVPC	NOBOX	221	O60393
RFPTQQTTCGPGPGH	ODF3B	56	A8MYP8
CQSPAHRPGAEGSPG	ZFYVE28	366	Q9HCC9
SPDVTAGCDPAGVHP	NSUN2	751	Q08J23
AATLAEPGPQPCLHI	ARHGEF17	1596	Q96PE2
EPGPQPCLHISIAGS	ARHGEF17	1601	Q96PE2
SLLGRFCGAEPPPHL	MFRP	371	Q9BY79
GTGVSHLCPEPPKTR	FAM47C	276	Q5HY64
SLRPEPPNTGVSHLC	FAM47C	641	Q5HY64
THSPSFPIPDRCEGN	MMP25	306	Q9NPA2
CSDAPHPLSKIPGGR	OAZ2	31	O95190
TLLGPLPHAAVPCSG	ESPNL	946	Q6ZVH7
TGAHPAAARPSGLVP	HOXC9	31	P31274
PDANLTVAHPGPCES	KAZALD1	156	Q96I82
TVAHPGPCESGPQIV	KAZALD1	161	Q96I82
LPAVRGDIPPGCAAH	HCFC2	61	Q9Y5Z7
EAGPQGCATEPRPHR	MAP1A	2431	P78559
GCATEPRPHRGELSP	MAP1A	2436	P78559
PSLCPPGGIHQVTIN	KRT73	96	Q86Y46
SNGVCPRDASHFPEP	LRIG1	871	Q96JA1
SSTEGPAAPLPLGHC	NCKAP5L	136	Q9HCH0
PAAPLPLGHCAGQRE	NCKAP5L	141	Q9HCH0
RHSPGPTPQPDCSLR	GREB1	1191	Q4ZG55
GEHRRGENPPTSCPK	INKA2	266	Q9NTI7
VQSEGPGAPAHSCSP	INPP5E	116	Q9NRR6
TPASAVHRPPLSACG	FAM149A	341	A5PLN7
IGPGIVLSNPDRPCH	GATM	311	P50440
HGERQSPGPEPSVCR	ITPRID1	816	Q6ZRS4
QPGAPRLEGSHCVEP	LGR6	906	Q9HBX8
DGHLQAVGSCPRLTP	NAB2	421	Q15742
AGKQHQPCRPIGTPS	GPBP1L1	166	Q9HC44
AEPPSGPEAAVNTHC	HIC1	201	Q14526
GPLAAAHSPGPCTVL	ASPDH	161	A6ND91
AVSPGCRDASLNHPP	MGAM	1431	O43451
HSNLLCRPGPGLGPD	KCNE3	26	Q9Y6H6
GRLPVHGTTDGPECP	KIAA1109	821	Q2LD37
PLANGPFSAGHVPCS	KDM6A	566	O15550
SHGCLPATRPPGSDL	KDM6B	346	O15054
PRGSPGDPAHLSCAS	LETM1	26	O95202
SPAAIHPCGNPTVIE	LMOD2	186	Q6P5Q4
HPQVRKIGVFSCGPP	DUOX2	1506	Q9NRD8
PQHRPCPGPSLADDT	PER1	31	O15534
RAGCPVPQRTHAGPS	PDCD7	156	Q8N8D1
RVHSPEGCPEILPSG	PLXNA3	676	P51805
AEAAVGPVPDSPLCH	PLXND1	91	Q9Y4D7
AHGVPPPDVICVRSG	ICAM5	516	Q9UMF0
PCSHALPQGLSPGQV	LGALS12	211	Q96DT0
VLTLCTRPFPIPHGG	NAT16	276	Q8N8M0
LGDHPAPTVNGTRPA	KIF21B	881	O75037
CHLGLPQPAGEAPAV	NFATC1	786	O95644
LLSPCTPNPCEHGGR	NOTCH3	771	Q9UM47
PAARDAGPQGLHPSV	DLG5	1211	Q8TDM6
GNLCLHVPNPPSGIS	HESX1	56	Q9UBX0
PTASGFCPHPGSVAL	KMT2E	1806	Q8IZD2
GPHACLHQPDAGPTI	LCT	1846	P09848
TLGPHSPEPLGVCRN	LRP3	736	O75074
PPKGLVRCAHSPIGE	SELE	436	P16581
SPTFPEHLGCAGSRP	NRIP1	1011	P48552
LAQAPAPDVPGCSRG	LAMB2	31	P55268
IVQRPGPVPAHSLCG	LAMB2	641	P55268
PLDGANVSCSPRPGA	KREMEN2	346	Q8NCW0
SPTHGPAPACRSGAA	KIF26A	1471	Q9ULI4
HFCSPGQAGVSPPRK	MICALL1	106	Q8N3F8
HSLCLQPDSGGPPEL	MEOX2	106	P50222
PPDTAASPRCHAQEG	MEFV	306	O15553
PSQPQSALECHPERG	AR	116	P10275
HPERGCVPEPGAAVA	AR	126	P10275
GSCDVPSPFNHRPGS	DBN1	306	Q16643
PVGPRAHCGDPVSLA	FGD3	36	Q5JSP0
EAGSCHPAGLAPVDP	LAMA5	721	O15230
APQDRLPHPCSSGFS	NYAP2	101	Q9P242
CPQALPPSVGAGHLI	PCDHGC4	576	Q9Y5F7
RCSVPEGPFPGHLVD	PCDHB10	726	Q9UN67
SVGRCSVPEGPFPGH	PCDHB15	721	Q9Y5E8
PSGLRAPPKSCQHNG	CHRDL2	101	Q6WN34
SDPGTHGPPCRIAAV	HECTD4	2181	Q9Y4D8
LCLGPAGPDSRPHLS	LBX2	176	Q6XYB7
AGVPGHSEAASCIPP	IRAK1	526	P51617
ATLPEPASPGRQACG	HGFAC	381	Q04756
CRPEVGAAGPPRSIH	MED26	111	O95402
LPGCPRHFNPVCGSD	SPINK2	41	P20155
PLNCSPDSLPVHIAG	NELL1	311	Q92832
CQGPELHPGVASIRS	LRIT1	251	Q9P2V4
TQLPCQHGRRPTAPG	CAMK1G	371	Q96NX5
QTPPGLCPLAGNSVH	REXO2	131	Q9Y3B8
PCPRGAPALQETGSQ	OBSCN	6256	Q5VST9
GPPAAQGCVPRHSVI	OBSCN	6856	Q5VST9
SVGRCSVPEGPFPGH	PCDHB14	721	Q9Y5E9
GSQVCRPPLLHGSLP	GATA3	81	P23771
HPPSVIFCLAGVGVP	GIG44	66	P09565
GHPDPPTESRSCSQG	BCL6B	166	Q8N143
AAAPGTCLDATPHGP	E2F2	56	Q14209
TPHGPEGQVVRCLPA	E2F2	66	Q14209
CPNPPAILNGRHTGT	CR1	1321	P17927
PCANTSLHPGLNPRI	CTTNBP2	431	Q8WZ74
SQPLPSTHRDPGCKG	FAM193B	351	Q96PV7
QGPPVTRHLCDGAIG	DCDC2B	106	A2VCK2
NTESPAGLHPLPRAG	DBNDD1	101	Q9H9R9
GGNPESRPDSPKCHA	DMRT3	211	Q9NQL9
PCHGPPLGAENFTVT	FCGBP	2101	Q9Y6R7
APCHGPPLGAENFTV	FCGBP	3301	Q9Y6R7
SATDGPLAPCHGLVP	FCGBP	3471	Q9Y6R7
SAPCHGPPLGAENFT	FCGBP	4501	Q9Y6R7
APTGIPCSEQAHGVP	CCDC9	456	Q9Y3X0
PAAPEPLGGICEHET	CEBPA	46	P49715
LCFIVHSPGAPAPAG	FBXL17	61	Q9UF56
SPAPRCELPVGAGSH	CR1L	536	Q2VPA4
GQGRSPAGAHPALCP	LINC00574	71	Q9H8X3
LHPPIPTFARGCTQD	CYP4F8	391	P98187
PQAEVGPTGCPHRSG	CBS	6	P35520
TPRSNPGGFGIAPHC	CENPV	226	Q7Z7K6
PELSTPSICHAPGGE	CRIM1	671	Q9NZV1
VSEAGPGPPQHLSCI	BTBD7	901	Q9P203
SPGPGHYLRCDSTQP	CSF3R	761	Q99062
PRCREPGTAHGAQTP	FRMD6-AS1	161	P0C7T7
PQDELNPIHCRGRGP	EDEM1	151	Q92611
CGDLPGLRTAVPPHE	MAP3K12	556	Q12852
PERIGGPEVTSCHLP	MARK4	631	Q96L34
SEAPEPVPRGCSGHG	MAST4	6	O15021
PVPRGCSGHGSRTPA	MAST4	11	O15021
TAGSHECLPGNPVRP	MAST4	1711	O15021
SPTHPGEGLVLRPLC	GNPNAT1	31	Q96EK6
GGSPRTACHLNPSPD	GRID1	121	Q9ULK0
GVPPQPRAAHTCAVL	KLHDC1	191	Q8N7A1
CAALLQTPGPHPGHQ	KLHDC9	191	Q8NEP7
PICAALPGGDPNHVT	KCMF1	111	Q9P0J7
LCLAPRDHSPPSQGS	DOK7	411	Q18PE1
HNSPELGRPPAAGVL	FAM83H	1066	Q6ZRV2
QAPGHLSGLSVPCPL	CACNA1H	671	O95180
NPVICPSAGSGGHPD	SLC38A9	251	Q8NBW4
NGHPPQGCASTPVAR	POLR3E	546	Q9NVU0
STGSVLELGLHCPPP	CREB3L4	21	Q8TEY5
CSSLRQHILPSPDGP	DELE1	136	Q14154
GPQDATHCSPVSLEP	IL17RC	26	Q8NAC3
SPSRHGALAELCPPG	MLPH	266	Q9BV36
DPPGPRVHTCSAAGG	PKD1	3761	P98161
NPPSAGPIVVHCSAG	PTPRK	1071	Q15262
ASPPEFCVLGHGLQP	PCARE	1251	A6NGG8
GLECPALQHRPSPAS	ARHGAP30	446	Q7Z6I6
ETPGPGAHCPEQVTV	ODF3L2	236	Q3SX64
SVGRCSVPEGPFPGH	PCDHB9	721	Q9Y5E1
PQLCRAGGLPRHPDA	MMP28	406	Q9H239
RCLADGNPPPHFSIS	MCAM	271	P43121
QDCHVPRAPAPGEGE	PHF1	116	O43189
PQDHRPTCPGVGTKD	NUTM2D	646	Q5VT03
PQDHRPTCPGLGTKD	NUTM2F	596	A1L443
PQDHRPTCPGLGTKD	NUTM2G	581	Q5VZR2
QRGGPCTNHEPPALE	POLG	11	A0A3B3IS91
SHCVEPEPSQVPGGS	SYTL2	466	Q9HCH5
GPATCGAPASPADHL	RAB11FIP1	871	Q6WKZ4
PPPAIASHSQRACLG	SOX3	381	P41225
TSPHAPGFPAEGRCG	TRMT13	6	Q9NUP7
QLHAGPATEEPGPCL	TACC3	446	Q9Y6A5
HTAACPSTPRAQGAP	RNF19B	691	Q6ZMZ0
APHGIPLCTGQHIPA	RNF38	206	Q9H0F5
KPHVPLGRNCSSLPG	GFM2	36	Q969S9
LGNTEAAHPPSPIRC	TMEM265	11	A0A087WTH1
LCPGPEHGRASSVLQ	SEMA4F	296	O95754
RDPCPHLGQILGETP	SPATA31C2	511	B4DYI2
PGGLHSTRQTKPCPQ	SSPOP	1791	A2VEC9
LAPGDTTCPGPHSQT	SSPOP	2861	A2VEC9
PPSKNGGAPCAGERH	SSPOP	4036	A2VEC9
PGHFRSQAGPCVPED	SSPOP	4971	A2VEC9
PPPQGGSQLGHCISE	TMEM121B	546	Q9BXQ6
PPGSGSLPCARLHAT	TMEM132A	151	Q24JP5
EPSSPQSLCHLVAPG	SYNE2	6386	Q8WXH0
RVTDHTCPSGGPLSP	TADA2B	131	Q86TJ2
AAQGHPDGPCAPRTS	SLC6A5	21	Q9Y345
TACVVGRPGPHPTQF	MAP3K21	971	Q5TCX8
CIPVHGFRPVKAPGT	NTN4	271	Q9HB63
GGPAQLQALAHRCPP	RECQL4	951	O94761
EVSGSSHCPLPAAPV	PIK3R6	626	Q5UE93
DPCPHLGQILGETPQ	SPATA31A7	666	Q8IWB4
CVGSDLGPAAHPVQP	PSD4	376	Q8NDX1
QPPPTGEVCHGSALA	SIM1	611	P81133
PATHPVLDQPCGQGL	SHROOM1	626	Q2M3G4
APNPPTFSELSHCRG	SHROOM2	986	Q13796
RPCPASQLPGLLSHG	TAOK2	936	Q9UL54
PSACGGLAHSAPLPA	OLIG2	186	Q13516
RHSSCPAPGLSPRQG	SEBOX	126	Q9HB31
FLSQHRCGEPEASPP	SLC25A48	86	Q6ZT89
VASPEHCPLSGREPS	STARD9	4036	Q9P2P6
VYGSSGHCVPPADPR	SUSD6	181	Q92537
EDAVSPPQAPHGGSC	EXTL1	66	Q92935
PDSHARCAQGQPPLL	SGCA	216	Q16586
VCIGHRDAPRASSPP	TRIOBP	1016	Q9H2D6
PTPVCIGHRDAPSFS	TRIOBP	1161	Q9H2D6
VCIGHRDAPRASSPP	TRIOBP	1216	Q9H2D6
PFKGLRCETGDHPVP	SNED1	416	Q8TER0
CALPPPQGQHSGARG	SLX4	926	Q8IY92
GRHPLCPGASPARQA	ABTB2	356	Q8N961
ACAHNPTGVDPRPEQ	GOT2	211	P00505
HLPAVPALNRTGDPG	CLCF1	21	Q9UBD9
AGGHSPAPPQTEECL	RECQL5	811	O94762
VLAPQPIPGGCHNSL	TCERG1L	216	Q5VWI1
HSCTAGPNPTLGRPL	TGIF1	271	Q15583
GSPTPQPNGECHSLG	TJAP1	281	Q5JTD0
DPCPHLGQILGETPQ	SPATA31A3	666	Q5VYP0
ARLHPTSCAPNGLNP	TNRC18	761	O15417
AQHPPPSGICRDLSD	TRAF3IP3	126	Q9Y228
PPGALPLAHVNGCAE	SLC30A10	416	Q6XR72
PHRPLSSDGVCPASL	RIN2	226	Q8WYP3
HSEPTRGAEPSCPQG	TBC1D17	101	Q9HA65
LRLCCAGPSQAHPGP	nan	96	Q96NJ1
AAAVAAPPHCPGGSA	ZC3H3	851	Q8IXZ2
VDAAGLRSPCPGQHG	TMC8	696	Q8IU68
LRSPCPGQHGAPASA	TMC8	701	Q8IU68
EPPSSHIQPGLCGLG	USP4	291	Q13107
NHPGCIPLEGPHSIS	ZBTB37	451	Q5TC79
PGRPELCFLPGTVNH	TTC24	481	A2A3L6
GAGSQSPPRGRCLHP	nan	11	Q6ZSN1
PVPHCERGLQPTLTN	VWF	2336	P04275
DPCPHLGQILGETPQ	SPATA31A1	666	Q5TZJ5
RPPAPTHVGAGSLCQ	SEC16A	411	O15027
VPPKCGHAGVPRESA	SPEM3	126	A0A1B0GUW6
DPCPHLGQILGETPQ	SPATA31A5	666	Q5VU36
FRGCSPLLTHGPGPA	TRAPPC14	116	Q8WVR3
PYQQPLRSGSGPHDC	PAPLN	616	O95428
SLDPTLAPPGCHVVS	PYROXD2	441	Q8N2H3
AGPCDPGEVALPHVA	SH2D3A	461	Q9BRG2
PPTGSCLRHSAQPTA	SH3RF3	586	Q8TEJ3
PQCEGHESRAAPTPG	SH3PXD2B	781	A1X283
AQPPGPGQELTHCTL	TBL3	286	Q12788
QPSRPGPGECTLDHG	TONSL	1356	Q96HA7
RGSDLPPDPHNCGKF	ZNF592	96	Q92610
AVLQPGCPSVGIPHS	VPS18	16	Q9P253
RLCHDPPTAPGSQAT	ZNF575	196	Q86XF7
PAPAVHCAAPRAAAG	SYT15B	66	X6R8R1
GTTPPENGLSEHPCE	SP100	196	P23497
PGSPSLCRHPAGVYQ	TNS1	1241	Q9HBL0
DCLGPPVPGARDSIH	TMEM102	161	Q8N9M5
LRTHLPGAQAAPCPS	ZNF775	356	Q96BV0
DAVPLATAPGHGPQR	AXL	176	P30530
APPCTAHLRDPGFTA	TMEM88	76	Q6PEY1
HDPAPRTVCNGGYTP	SORBS3	51	O60504
AGEPAILECQPPRGH	ROBO2	146	Q9HCK4
TGVPGHVPRSTCAPS	TACC2	1621	O95359
HPRLESPNSGSCSLP	TECPR2	271	O15040
LPTVTLGFPHCARGP	PRRG4	11	Q9BZD6
GPVFGPCSQLPRHTL	RLBP1	31	P12271
QKRSSPSEGLCPPGH	TNFRSF10B	71	O14763
CHQGPGPLRESLPSE	PRAG1	221	Q86YV5
GPADPAPSCRTNGVA	PRAG1	591	Q86YV5
RGPPDHQASALTCPG	TMEM88B	26	A6NKF7
SGPPSPHGTLRVCTI	PKD2L1	26	Q9P0L9
SPLGELCPPGSHRSE	TNFRSF10A	126	O00220
SEPNPRPVFGICLGH	CAD	241	P27708
GAAQRPQAGDPPHEC	ZNF517	356	Q6ZMY9
EHPAAPRLVPRGSCG	ZC3H12D	51	A2A288
TSLPHFPGCAGPTED	WDR62	1021	O43379
PTPGLAQGVHAPSTC	WDR62	1196	O43379
TVLQPCPHIPDSGLG	TNFRSF13B	266	O14836
PCPLHGGSRGPSTFL	ZSWIM8	646	A7E2V4
GQKPLSVHRPPTSGC	TSPAN10	16	Q9H1Z9
PGLGTPTPRRCAQGH	VWA5B2	91	Q8N398
GTASLHCDVSGRPPP	WFIKKN1	201	Q96NZ8
FPQAAHPGDCPELRS	ZXDA	211	P98168
LRPCGSPGSFLQHLP	ZNF843	196	Q8N446
PVACPRGSSPVTHEN	ZNF648	51	Q5T619
SLLNPGSPGGHACPA	ZDHHC8	481	Q9ULC8
PKERSPQSPGGNICH	ZNF576	16	Q9H609
AAPARGPRPHLQCGD	ZNF142	1161	P52746
APGSPAETTEGPLHC	ZNF142	1316	P52746
SVPSFINHPLVCGPA	TRUB2	71	O95900
GCVSPERGPTFNPKH	ZNF777	601	Q9ULD5
AESGGTPVRPCSRPH	WWC2-AS2	11	Q96NR7
ELPAPGHGCSFADPI	ULK1	801	O75385
CLHPGAQNIPSPTGL	TTLL5	946	Q6EMB2
ATPGAVQESCSPHPL	ZKSCAN5	151	Q9Y2L8
DPHPLSVVAGRPLSC	TRIM3	101	O75382
SDLQRDPPAHCSAGP	UBE2D1	11	P51668
DPAGLHGSQPPRRCL	XKR8	71	Q9H6D3
PGCSQRGLRTSPVHP	FAM53A	336	Q6NSI3
LQHSPEAACPPTAGT	KCNC4	616	Q03721
EGAHPAAAPAGCVPS	MYOZ3	121	Q8TDC0
PTPGCTGRGHVNSNR	MYT1L	551	Q9UL68